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Abstract
A laboratory information management system (LIMS) is central to the informatics infras-
tructure that underlies biobanking activities. To date, a wide range of commercial and open
source LIMS are available. The decision to opt for one LIMS over another is often influenced
by the needs of the biobank clients and researchers, as well as available financial resources.
However, to find a LIMS that incorporates all possible requirements of a biobank may often
be a complicated endeavour. The need to implement biobank standard operation procedures
as well as stimulate the use of standards for biobank data representation motivated the devel-
opment of Baobab LIMS, an open source LIMS for Biobanking. Baobab LIMS comprises
modules for biospecimen kit assembly, shipping of biospecimen kits, storage management,
analysis requests, reporting, and invoicing. Baobab LIMS is based on the Plone web-content
management framework, a server-client-based system, whereby the end user is able to access
the system securely through the internet on a standard web browser, thereby eliminating the
need for standalone installations on all machines.
The Baobab LIMS components were tested and evaluated in three human biobanks. The
testing of the LIMS modules aided in the mapping of the biobanks requirements to the
LIMS functionalities, and furthermore, it helped to reveal new user suggestions, such as
the enhancement of the online documentation. The user suggestions are demonstrated to
be important for both LIMS strengthen and biobank sustainability. Ultimately, the practi-
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vcal LIMS evaluations showed the ability of Boabab LIMS to be used in the management of
human biobanks operations of relatively different biobanking workflows.
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Chapter 1
Rationale
1.1 Introduction
Research projects in translational genomics and personalized medicine, irrespective of their
size, essentially aim to process biospecimens and associated data in order to elucidate disease
origin and etiology (Riondino et al., 2015; Smith and Aufox, 2013; Wilkinson et al., 2018).
The outcomes and findings of combinatorial research studies, are then further explored by
projects in other fields such as pharmacology and clinical trials, to develop and test therapeu-
tics that may improve human healthcare (Matimba et al., 2008). Scientists and researchers,
may for the purpose of their research projects, request biospecimens from biobanks, or col-
lect these biospecimens themselves. Research groups which utilise the services of a biobank
(which generally store high quality and regulatory body approved biospecimens), can con-
siderably reduce research turnaround (time to result) which is generally impaired by diffi-
culty and delays resulting from participant selection and recruitment, sample collection, and
regulatory process approval (Sarojini et al., 2012). Biobanking operations are becoming
more complex in terms of the continuously increasing quantity of the stored samples and
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the addition of highly sophisticated biobank instruments with high throughput capabilities
which have the potential to generate masses of non-human readable result files. Coupled
to this, the regulations governing biobanks are subject to revisions and modifications, and
best practices guidelines require continual refinement and adherence to maintain biospeci-
men chain-of-custody, and guarantee fit-for-purpose biospecimens (Bledsoe, 2017; Manders
et al., 2018). As a consequence, manual methods can no longer handle the increased migra-
tion and variety of inter- and intra- laboratory information, and as such, automation of labora-
tory data management is becoming a necessity. Automated systems and instruments, enable
biobanks to track and process a greater volume of biospecimens without need to hire and
train additional staff. In addition, automation benefits to biobanks includes the elimination
of errors, improvement of quality control, reduction in long-term costs and turnaround time,
and ultimately, improvements in patient safety (DeLone and McLean, 1992; Berman, 2015).
Automated systems include, but are not limited to, Laboratory Information Management
Systems, Electronic Medical Records and Experimental Management Systems. Laboratory
Information Management System (LIMS) applies computing technology for the integration
of laboratory workflow, biospecimen lifecycle traceability, data collection from a variety of
instruments and/or user input, notifications and reporting.
The Information Technology (IT) advancements to hardware performance, software de-
velopment tools, and networking, all positively impact on LIMS development (McDowall,
1993). Modern systems tend to therefore demonstrate greater robustness, flexibility, and
are easier to maintain. Many open source tools that provide valuable functionalities exist in
public repositories and the integration of these functionalities allows for reduced time and
cost associated with LIMS development. Open source tools are continuously maintained by
developer communities, which contribute to the enhancement of the tools, while fixing bugs
and attending to other issues within the source code. Wide Area Networking (WAN) tech-
nology has also influenced modern LIMS design, and newer information systems implement
http://etd.uwc.ac.za/
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a client-server architecture. Client-server based systems grant distant access to LIMS infor-
mation, report and notification reception, and real-time interaction using modern Graphical
User Interfaces (GUI) (Ulma and Schlabach, 2005). The implementation of LIMS can be
a long and costly process (Rasmussen et al., 2007), as it requires (1) identification of all
biobank operations and evaluation of automation ability, and whether their computerisation
will improve biobank efficacy, (2) establishment of selection criteria and feasibility assess-
ment of LIMS implementation, such as functionality lists, available budget, availability and
skill level of laboratory IT personnel, and implementation deadlines, (3) evaluation of LIMS
systems responding to the pre-established selection criteria. The evaluation verifies whether
the system functionalities adhere to the biobank requirements, (4) allocation of physical
resources for appropriate LIMS installation (Fig. 1.1). Moreover, workflows governing lab-
oratory operations may be partially, or totally, discordant which makes it particularly chal-
lenging to find a “one-size-fits-all” LIMS that meet all biobank requirements (Rasmussen
et al., 2007). Biobanks which are not able to make use of an existing LIMS may either; (1)
adjust the selection criteria level, (2) request support and customisation from vendors, or (3)
develop de novo, a tailored-made, in-house LIMS solution. The above-mentioned choices do
present important drawbacks for the biobank’s internal functioning. The first option may re-
sult in a reduction of automation levels which can reduce biobank efficacy, while the second
and third options will require additional time, human and material resource investment, and
may not fit with the selection criteria, timeline and budget (Kyobe et al., 2017). Biobanks
in resource limited settings are generally small, less equipped, and may not have a skilled
in-house IT team capable of developing and maintaining biobanking systems (Klingström
et al., 2016). Sustainability in research biobanks, notably those operating in Low andMiddle
Income Countries (LMIC), is mostly based on short term funding from philanthropic orga-
nizations, external funders, governments, and other initiatives. Therefore, the feasibility of
the aforementioned options may be further hindered (Kyobe et al., 2017).
http://etd.uwc.ac.za/
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Fig. 1.1 LIMS selection plan. The selection criteria are inferred from existent
laboratory resources and operations requiring automation, and are applied to the
available LIMS products in the market; commercial, open source and in-house.
LIMS systems responding to the criteria are tested and/or implemented.
http://etd.uwc.ac.za/
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There are a variety of commercial LIMS available on the market, however, they are ex-
tremely expensive. Licenses provided for commercial systems generally include a default
set of functionalities or modules, but additional costs may accumulate for every additional
customised requirement (Kyobe et al., 2017). Additionally, the headquarters of many com-
mercial LIMS suppliers are based outside of LMIC zones, and as such, additional expenses
may be incurred when the vendor specialists are required to travel to the biobank for physical
implementation and/or face-to-face training (Kyobe et al., 2017). Unlike commercial LIMS,
open source LIMS freely provide the totality of their source code in public repositories for
use, sharing and customisation. Nonetheless, biobanks may demonstrate a reluctance in the
implementation of an open source LIMS. This may be due to the opinion that open source
LIMS are considered as less mature and present lack in functionalities, technical support
and documentation, and standards and harmonisation (Piggee, 2008). Absence of technical
support, standards and harmonisation appears to be of greatest concern to biobank stakehold-
ers. Lack of support services can hamper biobank functioning if no other alternative solution
exists. Furthermore, absence of standards and harmonisation in LIMS development makes
data transfer difficult, via export/import functionalities, from one LIMS into another (Norlin
et al., 2012).
1.2 Objectives
Biobanks which collect and store human biospecimens and related data, play an important
role in the advancement of human healthcare through fostering research studies which aim
to increase medical knowledge. Biobanks facilitate collaborations between different stake-
holders from diverse backgrounds (donors, governments, scientific institutions, legal and
ethical bodies, not-for-profit and for-profit organisations) to concentrate efforts in research
while aiming to simultaneously strengthen biobank efficacy and governance (Yu, 2016).
http://etd.uwc.ac.za/
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Despite this, not all biobanks are benefiting from ongoing collaborative efforts and decision
making. This may be due to the biobank’s financial, geographical, and/ or political circum-
stances (Ciaburri et al., 2017).
LIMS implementation in a biobank can improve productivity, reduce costs, and aid in
inter- and intra- biobank network formation (collaborations), and as such the LIMS can be an
important factor in biobank sustainability. As stated previously, biobanks in resource-limited
settings may not be in a financial position to employ a commercial LIMS, and available
open source LIMS may not present as an attractive solution due to their possible inherent
limitations. The study presented here demonstrates the development of Baobab LIMS; an
open source LIMS developed for human population biobanks. Baobab LIMS was designed
to deliver most of the pivotal functionalities required by state-of-the-art human biobanks,
while remaining secure, scalable and easy to implement. Furthermore, we advocate its use
in the LMIC setting, to overcome the limitations associated with commercial LIMS, and
current open source LIMS.
1.3 Aims
The aims of this research project is to:
• Design and develop an open source LIMS for human biobanks. In this process, differ-
ent technology solutions of open source LIMSwere explored. The question of whether
to create a de novo LIMS, or customise an existing open source LIMS was addressed
• Evaluate the LIMS using a real test case. The NHLS - NSB Biobank implemented the
LIMS andwas used as a case study for testing all of the integrated LIMS functionalities
http://etd.uwc.ac.za/
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• Enhance the LIMS by taking into consideration case study feedback and suggestions.
Important motivations for enhancements were also obtained through implementing
and interfacing of the LIMS within other biobank systems
1.4 Scope
The thesis is organised into five chapters. The rationale provides a general overview of
the project and its importance in biobanking practices. The literature review (chapter 2)
details the concepts, roles, and importance of biobanks, particularly in Africa. Moreover,
a comparison between commercial and open source LIMS is used to motivate that an open
source LIMS may be more suitable for biobanks in resource limited settings. Furthermore,
some features of available open source LIMS are discussed in order to evaluate their usability
in this research project. Chapter 3, outlines the computer science techniques employed in
the design and implementation of the LIMS. The discussion and evaluation is reviewed in
chapter 4, and the additional benefits of the LIMS is demonstrated in a use case. The project
conclusions and further considerations are discussed in chapter 5.
http://etd.uwc.ac.za/
Chapter 2
Background
2.1 Introduction
The explosive technological advances of the 21st century, particularly with respect to health-
care, has improved human quality of life and, in so doing, has increased life expectancy
(Iskrov et al., 2017; Monteiro et al., 2018). The development of Computer, Robotic and Net-
work technologies has led to the creation of services in the economic, financial and healthcare
sectors, which are used in daily life andmay be considered essential to humanwelfare (Joseph
and Stone, 2003). Computational systems are present wherever management of information
is needed, such as banks, markets, universities, hospitals, and laboratories, to cite a few. Ser-
vices whichwere considered to be difficult and time consuming by both service providers and
consumers alike, are today offered with less effort and in a shorter time. Instances which
demonstrate the benefits of automation are numerous. For example, prior to automation,
banks required the physical presence of the sender, followed by manual entry of the transac-
tion information in a hard copy form. Manual checking of the information was a requirement
to achieve a monetary transaction between two parties. These days, monetary transactions
http://etd.uwc.ac.za/
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can be done using online numerical services that are accessible to clients by using a computer
linked to an internet network connection (Joseph and Stone, 2003). In terms of epidemio-
logical studies in human healthcare, bioinformatic institutes within universities make use of
the human reference genome, completed in 2003, to study the origins, causes and possible
treatments for diseases which are a threat to human lives (Lander et al., 2001; International
Human Genome Sequencing Consortium, 2004). This reference genome would not exist if
a robotic sequencer connected to computer systems with immense hardware storage, was
not developed (Lander et al., 2001). Prior to automation efforts, laboratory operations were
tracked manually in logbooks, and experimental tests, results and reports were tediously, and
often erroneously, written by hand (Prasad and Bodhe, 2012). Contemporary laboratories
are now equipped with computer systems and Laboratory InformationManagement Systems
(LIMS), that automate laboratory operations and generate legible and accurate reports using
the push of a button (Prasad and Bodhe, 2012).
A recent innovation which has been listed among the top 10 ideas changing the world
(Park, 2009; Kinkorová, 2016), is biobanking. This laboratory practice is playing an impor-
tant role in the scientific community. Biobanks are considered to be a reservoir that supplies
researchers with biospecimens (Riegman et al., 2008), the lack of which, can delay or even
end valuable studies at the onset. Biospecimens which are collected, generally from pre-
selected patients or populations, are intensively analysed in (amongst others) “-omics” and
drug discovery studies to understand the etiology of the disease affecting the selected pa-
tients or populations (Smith and Aufox, 2013; Vora and Thacker, 2015). Understanding the
intricate details of this revolutionary biobanking field, which is set to change biomedical
research, allows for greater efficiency in biobanking practices by automation technologies,
such as LIMS. In the sections which follow, the concept of a biobank will be further clarified.
http://etd.uwc.ac.za/
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2.2 Biobank Definition
The definition of a biobank has differed between organisations (Shaw et al., 2014), with the
term “Biobank” being interchangeably used with that of a “Biorepository” (Marodin et al.,
2012). Hewitt and Watson, (2013), in an effort to define a biobank, conducted a survey
asking participants a series of general questions. Participants were individuals who were
involved in the management of sample collections, and as such, would have existing knowl-
edge so as to best define what a Biobank is. The general consensus in the survey showed
that a Biobank is not only a sample collection system for human samples, but a system
which could be employed for collection of a variety of different species and subspecies. The
majority of respondents agreed that, to be called a Biobank, the management of sample col-
lection must follow professional standards and that biospecimens must have associated data.
Based on the combined findings, the authors proposed the following definition of the term
Biobank (Hewitt and Watson, 2013);
“A Biobank is a facility for the collection, preservation, storage and supply of
biological samples and associated data, which follows standardized operating
procedures and provides material for scientific and clinical use”
The definition above is, however, a general one, applicable to any kind of biobank and as
such, does not further define the meaning of “biological materials and associated data”. For
example, with respect to biobank collections of human samples, the South African National
Health Act defines a biological sample as; (Jordaan, 2016);
“…material from a human being including DNA, RNA, blastomeres, polar bod-
ies, cultured cells, embryos, gametes, progenitor stem cells, small tissue biopsies
and growth factors from the same.”
http://etd.uwc.ac.za/
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Associated data will include genetic, clinical, environmental and demographic information
of participants and/or donors of biospecimens (Parodi, 2015; Harrell and Rothstein, 2016).
Therefore, for the purposes of this study, a human biobank is defined as;
A facility for collection, preservation, storage, and supply of human biological ma-
terials including DNA, RNA, blastomeres, polar bodies, cultured cells, embryos,
gametes, progenitor stem cells, small tissue biopsies and growth factors, and data
derived therefrom comprising genetic, clinical, environmental and demographic in-
formation, which follows standardized operating procedures and provides material
for scientific and clinical use.
2.3 Biobank Classification
In the last two decades, the complexity and utility of biobanks have expanded rapidly
(Watson and Barnes, 2011; De Souza and Greenspan, 2013). Biobank capabilities have
developed from small facilities intended to store residual biospecimens of single studies
performed by single users, to large facilities comprised of several buildings (storage, labo-
ratories, oversight bodies) which store and analyse a variety of biospecimen types. Modern
biobanks follow strict standardized operations to preserve biospecimen and data integrity,
and supervise access to data and biospecimens by ethical institutions to protect study par-
ticipants (Watson and Barnes, 2011). The classification of biobanks assists stakeholders
in determining adequate actions to be undertaken towards biobank growth and sustainabil-
ity (Watson and Barnes, 2011; Hofman et al., 2013). For example, depending on the clas-
sification of a biobank, sponsors (funding bodies) may allocate varying levels of support
(funds), researchers may or may not request data and biospecimens, and biobank managers,
depending on the available resources, will be able to select the adequate system for laboratory
information management and automation.
http://etd.uwc.ac.za/
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In literature, biobank classification was found to depend on (1) type of biospecimen they
store e.g. tissue biobank (Campbell-Thompson et al., 2012), (2) specificity e.g. disease-
based and population-based biobanks (Cervo et al., 2013), (3) scale i.e. small, medium and
large biobanks (Roden et al., 2008) or (4) brand i.e. Commercial and Research biobanks (An-
derlik, 2003). However, the classification criteria above, may not serve in the best interests of
all biobanks and can hamper stakeholder activities related to the biobank. To this end, Wat-
son and Barnes, (2011), proposed to categorize biobanks via a mono-, oligo- and poly-user
system of classification, based rather on the number of users which the biobank is serving.
Mono- and oligo-user biobanks are generally considered to be small scale and as such, tend to
have less funding and resources when compared to poly-user biobanks (Watson and Barnes,
2011).
2.4 Biobank Importance
The main purpose for which biobanks have been established, is to empower scientific re-
searchers with resources to use in their research endeavours
(Doménech García and Cal Purriños, 2014). Biobanks provide (1) safe and secure storage
facilities to maintain biospecimens for short, mid, and long term usage, (2) distant access
via computer applications and/or catalogues linked to laboratory information management
systems (to filter biospecimen and associated data content), (3) secure biospecimen sup-
ply and shipment services (Day and Stacey, 2008; Pang et al., 2017). In the post-genomic
era, biobanks are oriented towards stratified medicine with the ultimate goal of precision
medicine (Hewitt, 2011; Kinkorová, 2016; Merdad et al., 2017), that is, personalized diag-
nostics and tailored individualised therapeutics (Fig. 2.1). Despite the paramount number
of publications demonstrating a reliance on these bio-resources, there is still a limited un-
derstanding of the importance and contribution of biobanks to medical research (Merdad
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et al., 2017). To overcome this, initiatives which have been proposed, acknowledge biobank
value by establishing a standard and clear citation of biobanks in published works which have
utilised the resources of a biobank, called CoBRA: Citation of BioResources in journal Arti-
cles (Bravo et al., 2015). The Bioresource Research Impact Factor (BRIF) has subsequently
been developed to quantify the impact and research outputs of biobanks as an alternative
to the classification based on biobank user numbers, as stated above. This impact factor
will be attributed to each biobank, in a manner similar to publication journals. As such, a
biobank with a high impact factor may have a greater reliability and contribution in terms
of biospecimens, when compared to one with lower impact factor (Bravo et al., 2015; Vora
and Thacker, 2015).
Fig. 2.1 Research evolution toward precision medicine. Precision
medicine ensures offering of the right personalised medicinal care to
the right patient at the right time (http://www.mpmi.manchester.ac.uk/
aboutprecisionmedicine/).
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2.5 Biobank Challenges
Biobanks are part of a complex network of diverse entities, each of whom have different
visions, objectives and requirements (Fig. 2.2) (Kinkorová, 2016). The biobank entity is
typically positioned at the bottom of the tree, where its internal functions are influenced by
the fluctuating needs of the upper external structures. For example, a key requirement of
a research unit is for samples of very high quality, while the primary objectives of a gov-
ernment and/or ethics body is the oversight and respect of a country’s laws and regulations.
External sponsors impact the usage and distribution of the biobank resources. Brief details
of the important challenges which face biobanks is provided in the sections below.
Fig. 2.2Biobank governance from external bodies. Government and ethical bod-
ies regulate biobanking operations, external funders set biobank objectives and
research units require fit-for-purpose biospecimens.
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2.5.1 Sample quality
The quality of biospecimens may impact positively, or negatively on the results of the trans-
lational phase of clinical and scientific research (Simeon-Dubach et al., 2012; De Cecco
et al., 2009). It has been found that a substantial proportion of published research data is
not reproducible (Moore et al., 2011). In USA alone more than 28 billion dollars are spent
each year on pre-clinical research projects which are irreproducible (Freedman et al., 2015).
In addition to the cost wasted on research and labour efforts, maintaining samples of incon-
sistent and/or low quality for undetermined periods before their identifications, presents an
additional drain on biobank resources (Vaught and Lockhart, 2012). Differences in the pre-
analytical operating procedures for handling samples within biobanks, has been implicated
as themain reason for irreproducibility of research results (Ellervik andVaught, 2015). In ad-
dition, combining result outputs obtained from samples of different origins may bias the final
results in a collaborative research study (Ellervik and Vaught, 2015). International initiatives
have been developed to standardize sample operating procedures, such as the International
Society for Biological Repositories (ISBER) (Vaught and Lockhart, 2012; Vaught, 2016).
The ISBER proposes guidelines and best practices related to standard operating procedures
(SOPs) for collection, processing and archiving of biospecimens and associated data, and
in this way, aims to promote harmonisation. Furthermore, ISBER accredits and certifies
biobanks who comply with these guidelines and best practices (Betsou and Sobel, 2013).
The ISBER guidelines are thoroughly reviewed and updated as new technologies and meth-
ods emerge, and current practices are revisited and consolidated with new SOPs to ensure
“fit-for-purpose” biospecimens. Currently, ISBER best practices and guidelines is in its
4th edition and was released in the beginning of 2018 (Campbell et al., 2018). To further
enhance development and adherence to regulatory requirements, societies/organizations in
the biobanking sphere are being establish with dedicated and applicable standard guidelines
for specific fields of research, such as the Canadian Tissue Repository Network Biobank
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Certification and the College of American Pathologists Biorepository Accreditation Pro-
grams (Barnes et al., 2016; McCall et al., 2018).
2.5.2 Social, ethical and legal considerations
Research biobanks which utilise human subjects, or human biological materials and their
derivatives, are subject to strict ethical regulations to ensure sensitive participant information
are protected (Hansson, 2009). For example, the study of genetic information may lead to
the elucidation of phenotypic abnormalities in participant groups, and could result in stereo-
typing or genetic exceptionalism (Green and Botkin, 2003; Vassy et al., 2015). As such,
revealing genetic and health information publicly may harm participant integrity and due to
the inheritance property of genetic information, harm can further extend to the participant’s
relatives and community, and result in stigmatisation (Green and Botkin, 2003). In addition,
the repeated and suspicious use of participant health information will negatively influence
the public trust in biobanks (Caulfield and Murdoch, 2017).
The protection of donors is the responsibility of ethics committees. The South African
regulation Act No 61.2003, authorizes only health-related research studies approved by an
ethics committee, to collect and analyse human samples. The ethics committee requires in-
formed participant consent before approving a research proposal (Abayomi et al., 2013; Bol-
shete, 2015). The consent must (1) take into consideration and respect the participant’s social
and tradition beliefs, (2) clearly state the intention of the use of the samples with the excep-
tion of a broad consent in which samples can be reused in future-oriented research (Sheehan,
2011), (3) specify the possibility of return of research results and incidental findings to the
consented participant (Appelbaum et al., 2014).
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Furthermore, de-identification by anonymisation, or pseudonymisation, of the partici-
pant identity must occur. Anonymisation completely destroys the link between the individual
and the sample information (Elger and Caplan, 2006). This destruction of the link between
phenotypic and sample information, in certain studies, makes the interpretation of the re-
sults of a sample analysis difficult (Wallace, 2016). In contrast, pseudonymisation stores the
participant, sample, and linked information in different storage databases (applications) with
access granted only to authorized and trusted individuals (Strech et al., 2016).
2.5.3 sustainability
Sustainability is the capacity to “remain diverse and productive over time” (Watson et al.,
2014). Biobanks mostly depend on external funding in order to sustain their operations,
however, these funds may not be reliably guaranteed (Vaught et al., 2011; Henderson et al.,
2015). Three pillars underpin sustainability; financial, operational, and social (Watson et al.,
2014).
Financial dimension: encompasses three key areas; market strategy, customer focus, and
brand recognition. From within these areas, the fundamental elements are the development
and maintenance of a strategic business plan, and the cost recovery, generally by user fees.
Operational dimension: related to the (1) internal functioning of the biobank, that is, the
operating practices followed to collect, process and maintain high quality biospecimens and
associated data, (2) methods used to obtain clear and simplified consent forms, (3) mecha-
nisms and systems in place to request data and biospecimens, and facilitate access to these.
Social dimension: encompasses two main aspects; community engagement, and accredita-
tion and certification. The community engagement helps to educate, gain and retain public
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trust, thereby enhancing donor enrolment. Accreditation and certification helps to gain trust
of researchers, consumers and funders, thereby enhancing biobank utilisation.
The abovementioned dimensions cannot, however, be considered mutually exclusive of
one another. In conjunction with general sustainability techniques, the efficient use of re-
sources can reduce unnecessary expenditure and this cost reduction strategy is invaluable in
biobank sustainability. For example, the number of biospecimens within a biobank accu-
mulates over time and therefore decreases storage availability. Shea and co-workers, (2017),
found that multiple freezers used in biorepositories are not optimally exploited, with 30% of
their capacity unused. In this study, a storage assessment at the freezer and box levels helped
to save 4055 boxes and 10.2 freezers in 23 collections (Shea et al., 2017). Similarly, adopting
an open source technology for the automation of samplemanagement information, may addi-
tionally economize the mostly excessive cost of laboratory information management system
implementation (Kyobe et al., 2017).
2.6 Biobanking in Africa
Historically, Africa has been more greatly burdened by epidemic diseases, and the continent
continues to register the highest prevalence of infectious diseases (Malaria, TB, HIV/AIDS)
(Barr et al., 2016). More recently the Ebola virus caused thousands of deaths in Western
Africa (Troncoso, 2015). Additionally, a noticeable increase in non-communicable disor-
ders has been observed on the continent and it has been predicted that by 2030, 80% of
cancer deaths will be in Low- and middle-income countries (LMIC), and Africa is expected
to carry the major cancer burden (Mathers and Loncar, 2006; Ogunbiyi et al., 2016). In
terms of infectious diseases, the expansion of the global transport network has the capacity
to accelerate the spread of pathogens and their vectors and subsequently enlarges the infec-
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tion boundaries within, and outside Africa (Tatem et al., 2006). Given this critical health
situation, scientific communities have urged African national governments and international
world organizations to take immediate action to prevent the intensification of health deteri-
oration of African citizens. A review by Abayomi and co-workers, (2013), made note that
the lack of biobank and bioinformatics infrastructures would negatively impact the ability
for a rapid and efficient response to global outbreaks. The authors illustrated the urgent need
to establish these two invaluable infrastructures locally in Africa, and close to the regions
with high epidemic risks (Abayomi et al., 2013). In addition to considerations for the in-
stallation of physical infrastructure, the general lack of personnel skilled in biobanking and
bioinformatics, must also be addressed, if the initiative is to be successful (Mulder et al.,
2016).
In response, national governments and international organizations have noted warnings
from the scientific community with regards to the dangers, and likely fatal consequences of
global outbreaks. In the last decade, several biobanks were created in Africa through national
and international collaboration initiatives such as the HumanHereditary andHealth in Africa
(H3Africa), the AIDS Cancer Specimen Resource (ACSR), and the Bridging Biobanking
and Biomedical Research across Europe and Africa (B3Africa) projects
(www.h3africa.org/consortium/projects, http://oham.cancer.gov/oham_research/programs/
specimen_resource, www.b3africa.org). H3Africa for example, has funded the creation of
three new biorepositories in South Africa, Nigeria, and Uganda. Furthermore, the
H3ABioNet, a pan-African bioinformatics network for H3Africa, was established to support
the development of bioinformatics capacity and promote scientific and biomedical research
in Africa (www.h3abionet.org). The B3Africa project complements the work of H3Africa
and aims to establish a harmonized ethical and legal framework for biospecimen and data
sharing between the African and European continents. In addition, the B3Africa partnership
is investing in the development of biobanking and bioinformatics open source systems and
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tools, grouped in a ready to install virtual machine box (http://bibbox.bbmri-eric.eu). The
work presented in this thesis, Baobab LIMS, is funded by the B3Africa project andwas devel-
oped to manage biospecimens in biobanks operating in resource-limited countries (Bendou
et al., 2017).
2.7 Laboratory Information Management System (LIMS)
An information system (IS) is defined as a set of components for collecting, storing, and pro-
cessing data to provide information, knowledge, and digital products to support the manage-
ment operations in an organization (Berisha-Shaqiri, 2014). Information systems are used
by a variety of organizations (markets, laboratories) to perform and manage their operations,
interact with their clients, and compete in the marketplace (Ranisavljević et al., 2012).
A Laboratory Information Management System (LIMS1) is an example of an IS mainly
used in biobanks and laboratories (Olund et al., 2007). As biobank practices have evolved,
so too have the requirement specifications for LIMS; from simple spreadsheets to highly
sophisticated web-based client-server applications (Fig. 2.3). These adaptive information
systems manage the information resulting from biobank operations and follow the whole
lifecycle of a biospecimen, starting from the collection of the sample through to transport,
processing, analysing, archiving and destruction of the sample (Fig. 2.4) (Moore et al., 2011;
Redrup et al., 2016; Campbell et al., 2018).
1Also called BIMS for Biobank Information Management System
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Fig. 2.3 Timeline outlining the evolution of LIMS. LIMS started as in-house de-
velopment fulfilling requirements of a specific biobank, and evolved into sophis-
ticated web-based application targeting wide range of biobanking workflows.
Adapted from (Prasad and Bodhe, 2012).
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Fig. 2.4 Biospecimen life cycle workflow operations. Collected biospecimens
undergo quality control analyses. Depending on quality obtained, biospecimens
are either analysed, stored, or discarded and destroyed.
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2.7.1 Sample collection
Generally, the collection of biospecimens is initiated within a research study targeting a spe-
cific disease, or a population behaviour (Capocasa et al., 2016). The collection of a sample
may occur in the same vicinity hosting the biobank, for example in a hospital, or from a dis-
tant location, in the field, using ambulant laboratories. In some cases, a LIMS may foresee
the type and the number of biospecimens expected to arrive at the biobank. In such cases, the
biospecimens are created with unique barcodes, in the system prior to their arrival. Further-
more, certain biobanks may assemble kits containing empty barcoded tubes and ship them
to the field where collection takes place. Upon receipt of biospecimens, information such as
barcodes, date of collection and sample types are checked for consistency and logged into
the LIMS.
2.7.2 Sample transport
Following collection, the biospecimens are transferred to the biobank via an internal, or
external courier. Ideally, the LIMS should be able to track information about the date of
shipment, date of arrival, and other pertinent information regarding the transportation of the
sample (such as temperature, package condition, adherence to shipping instructions).
2.7.3 Sample processing
Once a biospecimen is received, the biobank may routinely perform a quality control check
on the biospecimen. For example, if a whole blood sample is received and DNA is extracted,
an analysis may be performed to check the concentration of the extracted DNA in order to
verify that the biospecimen analyte has not degraded. Depending on the results of the QC
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check, the biospecimen is either discarded, or processed further into aliquots and derivatives,
and prepared for archiving. The result of the QC analyses, a log of the aliquots generated,
and the biospecimen volumes should be tracked in the LIMS.
2.7.4 Sample archiving
The biospecimens which are vetted by the QC verification can be stored at an extreme low
temperature in freezers and/or liquid nitrogen tanks (depending on the sample storage speci-
fications). Exposing a sample to sudden freezing may undermine the structural integrity and
stability of the sample components (cells, tissue) and as such, best practices for Cryopreser-
vation and Biopreservation techniques are recommended (Baust et al., 2009). For example,
there exists a cryopreservation method which allows direct transition of the biospecimen
from liquid phase to glassy phase while avoiding the crystal formation phase that would re-
sult in cellular injury (Rall and Fahy, 1985). The exact storage location of the biospecimens
and the temperature of the equipment in use for storage is critical information which must
be tracked in the LIMS.
2.7.5 Sample analysis
The main objective of storing biospecimens is to use them in downstream analyses. The
biobank may receive requests (generally from researchers) for biospecimens and/or their
derivatives (aliquots). In response, the biobank curates the biospecimens in kits, in order to
ship them to the defined destination. Large scale biobanks may have associated laborato-
ries which are equipped with high throughput instruments, thereby enabling analyses to be
performed within the biobank (Végvári et al., 2011). The LIMS should provide options to
track the analyses which have been performed on a sample, the volume used, and the results
http://etd.uwc.ac.za/
2.8 LIMS benefits 25
obtained. Furthermore, notifying clients by emailing them automatically generated reports
which detail the analysis results, is a functionality that should ideally exist in the LIMS.
2.7.6 Sample destruction
Destruction of a specimen may be called for if one or more of the following circumstances
occurs (Campbell et al., 2018);
• Low quality due to failure to adhere to pre-analytical procedures, equipment failure,
or repeated freeze/thaw cycles
• Absence of associated data to recognize the identity of the specimen
• Error in consent, or participant withdrawal
The LIMS must therefore provide options to deactivate, or completely remove biospecimens
and associated data from the system.
2.8 LIMS benefits
A LIMS may provide multiple benefits for all biobank stakeholders as it assists to;
Increase accuracy and speed of laboratory workflow process
Many biorepositories still rely on manual processes for recording laboratory information,
despite the time constraints this imposes on the laboratory activities and the high possibil-
ity of inaccuracies due to human error (Magzumova, 2016). The drive behind laboratory
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information management systems (LIMS) is to enhance biobank productivity and data qual-
ity (Dubey et al., 2012). As stated in ISBER best practices and guidelines, “the employment
of a validated LIMS for automation of the biospecimen lifecycle is considered an obliga-
tion” (Campbell et al., 2012).
Manual entry of elaborate information, for example barcodes, increases the risk of tran-
scription errors. With a LIMS in place, it is possible to rapidly scan and attribute a barcode
to a biospecimen. Moreover, interfacing laboratory instruments with the LIMS allows for
the automatic capture of high throughput data, and provides functions to verify the captured
data, which therefore improves data quality assurance (McDowall, 1988).
Strengthen data integrity and safety
A LIMS provides functionalities to securely store data for long term periods, with the addi-
tional possibility to create replicates and back-ups of the entire data collection in different
storage locations. Furthermore, details on changes in the captured data (insertions, updates
and deletions) and the user responsible for the changes are automatically tracked in LIMS.
This tracking of changes is particularly important in cases where data may have been com-
promised. In such cases, it must be possible to hold responsible person(s) to account and
take corrective measures, such as a reversion to the original state.
Improve data accessibility and control
Previously, searching a sample in paper lab notebooks was similar to finding an English word
in a dictionary. In a LIMS, a barcode will suffice to automatically fetch, almost instantly, all
information about a biospecimen linked to the barcode provided. Additionally, it is possible
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to access biobank information remotely, and securely, to further generate automatic statistical
reports using the LIMS web capabilities.
2.9 Considerations for LIMS selection
An ideal LIMS will cover the majority of the biobank operations. However, to identify the
ideal LIMS is both a complex and challenging process (Edward et al., 2008). Biobanks run
different operational workflows and many of these workflows are not publicly available. As
such there exists no standard LIMS that meets the requirements of all the existing work-
flows. Even if one application was created, the final LIMS product would be of incredible
complexity which in its essence, would undermine the viability of the system. A premature
and uninformed decision of which LIMS to use in the laboratory, may cause the automation
objectives to fail and waste considerable time and budget investments (Mahaffey, 1990). The
following considerations should be taken into account when choosing a LIMS;
• The system features must match the laboratory user requirements (Table 2.1)
• There should exist flexibility to accommodate evolving laboratory requirements. This
may also have a positive impact on biobank sustainability
• Existence of demonstrable robustness of the system backend functionalities (database,
backup system)
• The ease of use and availability of technical support, online documentation and train-
ing from the system vendor
• The budget allocated for the implementation of the system
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Despite the existence of a system which meets the above considerations, laboratory per-
sonnel may exhibit a certain hesitance and/or resistance to change the laboratory operational
protocols (Long, 1992). Additionally, employees may consider the automation process as a
possible threat to career stability. Biobank managers should therefore make their personnel
aware of the benefits of LIMS for the advancement of the laboratory, and involve them in the
process of LIMS selection, especially considering that they may be more cognizant of the
operations that require (or will benefit from) automation (Yu and Wilkerson, 2017). Lab-
oratory personnel will be both positively and negatively influenced by the implementation
of the LIMS. For example, while productivity may increase in the long term, adjustment
and training may influence schedules and increase workload, in the short term (Avery et al.,
2000)
Other specifications for LIMS selection have been outlined in Chapter 1 and additionally
in the workflow illustrated in Fig. 1.1.
2.10 Commercial and open source LIMS comparison
One of the primary considerations to take into account following the decision to implement
a LIMS, is whether to buy an off-the-shelf system, or develop a custom-built open source
LIMS (Dermody et al., 2006). A comparative analysis of the pros and cons (as they relate to
the operational dependencies of the biobank) will assist stakeholders in deciding which of the
many available options to move forward with. There are differing opinions as to which ver-
sion of a LIMS to implement and biobankmanagers may exhibit a preference for commercial
LIMS over the open source technology (Avery et al., 2000), and vice versa (Bhandari and
Snowdon, 2010). Table 2.2 highlights the differences and similarities between commercial
and open source LIMS technologies.
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Table 2.1 A list of typical LIMS features and requirements for the management of a human
biobank.
Feature Description
Sample tracking Log information of operations performed on a sample and all states
of the sample progression
Sample storage Represent biobank storage as a hierarchy of sub storage levels
(Freezer, shelf, box, positions) to precisely provide, and find a
sample position in the storage
Inventory
Management
Allow supply orders with a possibility to automatically adjust and
track inventory storage quantities
Instrument
integration
Interface with instrument to allow automatic upload of analysis
results
Lab analyses Log all information on analyses performed, samples used, analysts,
and results
Reporting Automatic client notification containing generated reports of analysis
results
Invoicing Automatic client billing and invoicing
Table 2.2 A feature comparison between open source and commercial LIMS products.
Open source Commercial
Initial cost Free Ranges in cost
Maturity Lower quality and insufficient
functionalities
Turnkey product with possible of
lack in functionalities
Customisation Source code available publicly
for customisation
Customisation only possible by
the vendor
Support &
documentation
Generally, poor quality support
and old or non-existing
documentation
Excellent support service, with
well written documentation,
however, there may be an
associated cost for this
Personnel Community of developers with
different levels of expertise and
time dedicated for the project
Well structured organisation with
full time skilled developers and
managers
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It is evident from the above comparison that commercial LIMS are more advanced than
open source systems. Nevertheless, in view of the complexity and heterogeneity of biobank
workflows, customisations are often necessary, regardless of the technology selected. More-
over, small customisations (that are in most cases associated to very high cost) are not always
appealing to vendor services, and not all biobanks have the financial resources to entertain
such customisation from the vendor. Resource limited biobanks cannot afford the expenses
of a commercial LIMS and as such, open source LIMS technology is the best alternative
solution (ARSLAN, 2014).
2.11 Open source LIMS examples
There are numerous open source LIMS available in themarket, however, themajority of them
were designed to manage very specific experimental data types, such as proteomics or Next
Generation Sequencing (NGS) (Helsens et al., 2010; Scholtalbers et al., 2013). Therefore
they cannot be used in biobanking automation. Below, a brief description of the two most
well-known open source LIMS is provided;
2.11.1 OpenSpecimen
Previously known as caTissue, Openspecimen was initially developed under the caBIG pro-
gram using U.S. National Cancer Institute funding (McIntosh et al., 2015). In 2011, the
caBIG funding program ended and a community of developers from India took over the
maintenance of the caTissue source code. In May 2014, caTissue was renamed to Open-
Specimen to underline the fact that caTissue is not only restricted to cancer diseases, and
is an open source tool. From the official website (www.openspecimen.org), Openspecimen
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is used in more than 65 laboratories worldwide. OpenSpecimen is a web-based application
written in Java technology with aMySQL database management system used for the backend
information storage. OpenSpecimen features and drawbacks are shown in Table 2.3.
Table 2.3 A list of implemented features and certain drawbacks of OpenSpecimen LIMS.
Features Drawbacks
Sample tracking Lack in functionalities
– Laboratory instrument integration
– Supplier orders and inventory storage
– Kit assembly
– Client analysis requests and services
– Reporting of analysis results
Biospecimen storage Source code complexity. Over 4 million source
code lines
Biospecimen shipment Expensive implementation and support services.
From the official website, implementation is
estimated at $45 000 US and support at $25 000 US
per annum
APIs for integration with other
third-party systems
User authentication and
authorisation
2.11.2 Bika LIMS
Bika LIMS (www.bikalims.org) was developed in 2002 as a pilot, for management of labo-
ratory information in the wine industry. The system has since seen a remarkable growth with
major releases for water quality management and inter-laboratory proficiency testing. Bika
LIMS is a web-based application written in Python, built with modern application server
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and content management system employing the Zope and Plone frameworks. Bika uses
ZODB, an object non-relational database, for information storage. Bika LIMS features and
drawbacks are shown in Table 2.4.
Table 2.4 A list of implemented features and certain drawbacks of Bika LIMS.
Features Drawbacks
Sample tracking Lack in functionalities
– Storage and freezer management
– Supplier orders and inventory storage
– Kit assembly
– Creation of batch of biospecimens
– Biospecimen shipment
Laboratory instrument integration Has not been implemented in biobank management
Client analysis requests and
services
Expensive implementation and support services
APIs for integration with other
third-party systems
User authentication and
authorisation
Bika LIMS incorporates a powerful laboratory analysis workflow (Fig. 2.5). Briefly, a
client initiates a request for a sample analysis and a laboratory analyst performs the analysis
on the sample and captures the results in the system. A lab manager must verify the results
as a QC check and in the case where a result cannot be verified, it is rejected and tested again.
At the end of the process an automatic report containing the analysis results is generated and
sent to the client using an email notification system.
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Fig. 2.5 An overview of the Bika LIMS analysis workflow. A client requests a
biospecimen for analysis. The analyst performs the laboratory experiment and
capture the results. The laboratory manager verifies the analysis results and for-
ward them to the client in a report format (www.bikalims.org).
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2.12 Summary
The resources and information kept within biobanks are necessary to enhance scientific re-
search in a variety of fields. The management of these resources and the associated data is of
vital importance to ensure consistency of the information and quality of the resources. There
exist numerous laboratory information management systems (LIMS) capable of advancing
laboratory productivity. Commercial LIMS are expensive to implement and to customise,
whereas open source LIMS may lack functionalities, yet they are customisable due to the
availability of their source code under licenses that provide rights for customisations. In
the chapter which follows, the development of a LIMS with novel functionalities currently
lacking in other existing open source biobanking solutions is discussed.
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3.1 Abstract
A laboratory information management system (LIMS) is central to the informatics infras-
tructure that underlies biobanking activities. To date, a wide range of commercial and open
source LIMSs are available and the decision to opt for one LIMS over another is often in-
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fluenced by the needs of the biobank clients and researchers, as well as available finan-
cial resources. The Baobab LIMS was developed by customizing the Bika LIMS software
(www.bikalims.org) to meet the requirements of biobanking best practices. The need to im-
plement biobank standard operation procedures as well as stimulate the use of standards for
biobank data representation motivated the implementation of Baobab LIMS, an open source
LIMS for Biobanking. Baobab LIMS comprises modules for biospecimen kit assembly,
shipping of biospecimen kits, storage management, analysis requests, reporting, and invoic-
ing. The Baobab LIMS is based on the Plone web-content management framework. All
the system requirements for Plone are applicable to Baobab LIMS, including the need for a
server with at least 8 GB RAM and 40 GB hard disk space. Baobab LIMS is a server-client-
based system, whereby the end user is able to access the system securely through the internet
on a standard web browser, thereby eliminating the need for standalone installations on all
machines.
3.2 Introduction
Human biobanking refers to the collection, processing, and storage of biospecimens and the
collection of associated demographic and clinical data for future research use. The extensive
collections of biospecimens throughout Africa collected for either specific research, popula-
tion studies, or part of normal diagnostics workup were not necessarily collected for prospec-
tive use by researchers and practitioners. As a result, such collections might not necessarily
have followed or adhered to evolving bioethical paradigms and international biobanking best
practices (ISBER, 2012; Abayomi et al., 2013).
However, the establishment of the concept of centralized biobanks across Africa through
initiatives such asH3Africa, theAIDSCancer SpecimenResource (ACSR), and the B3Africa
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(www.h3africa.org/consortium/projects, http://oham.cancer.gov/oham_research/programs/
specimen_resource, www.b3africa.org) projects has highlighted the need for establishing
and harmonizing national and regional biobank governance frameworks to address a rel-
atively unregulated access to human and other ecological samples of academic interest in
Africa. At the same time these governance frameworks fall in line with rapidly changing
biobanking practices driven by modern technology (Dhai, 2013; de Vries et al., 2014) Sim-
ilarly, a governance framework for IT infrastructure requirements that underlies a biobank
does not exist yet.
According to the biological material tracking recommendations within the ISBER best
practices, a computer-based inventory system should be in place to allow for the tracking
and annotation of each incoming biospecimen into the biobank (ISBER, 2012). A laboratory
information management system (LIMS) is thus central to the informatics infrastructure that
underlies biobanking activities. To date, a wide range of commercial and open source LIMSs
are available and the decision to opt for one LIMS over another is often influenced by the
needs of the biobank clients and researchers, as well as available financial resources.
The National Health Laboratory Services (NHLS)—Stellenbosch University Biobank
(NSB), a unit associated with the Division of Haematology at the Faculty of Medicine and
Health Sciences, was established in 2012 initially through the ACSR project, and subse-
quently the NIH H3Africa funding initiative and required options for an LIMS implemen-
tation. The only option at the time was to consider a commercial LIMS because of time
constraints to meet the growing need for biobanking services in South Africa. However,
access to open source LIMS software allowed us to consider a longer term implementation
that would align with our sustainability plans. Bika LIMS (www.bikalims.org) and CaTis-
sue (now evolved and known as OpenSpecimen (www.openspecimen.org)) were identified
as long-term options based on input from active software developer and user communities.
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The Bika LIMS, although not specific for human biospecimens, is part of the BIKA soft-
ware ecosystem that includes a BIKA Health for healthcare laboratories and Bika Interlab
for interlaboratory proficiency testing. Customization of the Bika LIMS software would pro-
vide the benefit of inheriting a range of electronic health record functions that are central to
establishing a core facility to support personalized medicine research. The recently funded
European project, B3Africa, was established to strengthen IT infrastructure and ethical gov-
ernance frameworks that would bridge biobanking and biomedical research across Europe
and Africa. This funding provided the impetus to revisit the biobanking IT infrastructure
at the NSB and to accelerate the development of Baobab LIMS, an open source LIMS for
biobanking, as a strategy to provide a harmonized LIMS as an option for Africa.
A functional specification exercise (http://christoffels.sanbi.ac.za/index.php/projects/
biobanking) in 2013 within the context of NSB biobanking requirements identified the fol-
lowing key modules as part of the extension to the existing Bika LIMS software, namely
biospecimen kit assembly, shipping of biospecimen kits, storage management, analysis re-
quests, reporting, and invoicing.
3.3 Implementation
Standard operating procedures (SOPs) associated with biological material inventory man-
agement were developed by the NSB team to inform LIMS workflow development. Other
SOPs focusing on shipping, labeling, biospecimen procedures, and quality control were
also developed in association with other H3Africa biobanks, and are publically available
(http://h3africa.org/consortium/documents). The collection of SOPs underlies the NSB
flowchart of biobank activities (Fig. 3.1) and subsequently the quality management sys-
tem. Importantly, even with the use of electronic systems, it is important to keep hard copies
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of all documentation detailing the biospecimen passage from reception throughout storage
to dissemination as a QC check.
Fig. 3.1 Flowchart of the activities within theNSB biobank. The activities within
the NSB Biobank starting with a face-to-face meeting with a client to the final
storage of the biospecimen and/or the analyses associated with that biospecimen.
3.4 System Architecture
3.4.1 Hardware and software
Baobab LIMS is based on the Ploneweb-contentmanagement framework (https://plone.org).
All the requirements for Plone are applicable to the Baobab LIMS. As such, the Baobab
LIMS is a server–client-based system, whereby the end user is able to access the system
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through the internet on a standard web browser, thereby eliminating disruptive workstation
installations and inefficient software maintenance.
3.4.2 Workflow description
The following processes and tasks were carried out by the NSB and the client to ensure that
a biobank project is successfully implemented (Fig. 3.1):
(a) The biobank laboratory manager meets with one or more client representatives to
decide on the requirements of a new biobank project. A client does not refer to a physical
person but rather to an institution such as a laboratory, a hospital, or even another biobank
that can be represented by one or more representatives. In the Baobab LIMS system, they are
called “Client Contacts.” The project requires both parties to define the specimen types that
will be collected and the biological analyses that are required at the biobank for all collected
specimens. (b) The biobank prepares and assembles the kits that include equipment needed
by the client to perform the sample collection, with one kit per participant. Mostly, a kit
contains empty barcoded tubes and a form with a field for participant identifier, generated
by the client. The collection forms are pre-barcoded with space for the client to use different
barcodes for the tubes. In this way, the design of the forms minimizes the risk of assigning
the incorrect tube to a participant. (c) The biobank ships the kits to the client by making
use of external courier services. (d) The client receives the kits, collects the specimens in
the associated tubes, and returns the kits to the biobank. (e) The biobank receives the kits
from the client and registers the biospecimens in the system. (f) The biospecimens are then
aliquoted for downstream analyses (the analyses defined in the project) or stored in freezers
for later analysis.
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3.4.3 Workflow implementation
The Boabab LIMS modules were designed to suit most laboratory specimen workflows,
with minimal customization and postinstallation. In the NSB biobank, these modules were
adapted to suit the specific needs as set out in the SOPs that were developed. These SOPs
described in detail the life cycle of a specimen as it moves through the laboratory, and which
steps require specific documentation, such as the time the samples arrived in the laboratory,
the time at which sample accessioning took place, which user was performing the analysis,
the method used in the analysis request (linked to its own SOP), and the time of completion
of the task, to name a few. In this way, the LIMS was able to adapt to almost all of the
manual documentation processes that occur in this specific workflow.
Client and analysis request modules were imported from Bika LIMS into Baobab LIMS
and customized to accommodate human biospecimen laboratory services. The following
modules were custom built to support the routine activities of NSB (Fig. 3.1).
3.4.4 Kit assembly
The biospecimen Kit assemblymodule provides the protocol needed to assemble kits that
will be used to collect biospecimens in the field (Appendix B (Supplementary Data) and Sup-
plementary Figs. B.1–B.3; SupplementaryData are available online at www.liebertpub.com/
bio). This module ensures that clients can order the appropriate kits for their biospecimen
collection. The project that is registered at NSB will define the appropriate collection kit(s).
For example, if a project will collect samples for DNA and RNA extraction at the client’s
laboratory, then the appropriate collection tubes with an assigned function and label must
be shipped to the client for immediate implementation in the field or for storage under ap-
propriate conditions until it is needed. The NSB maintains an inventory of kit components
http://etd.uwc.ac.za/
42 Baobab LIMS: Development of an open source LIMS for human biobanking
that can be put together and packaged for different sampling procedures and sample types
depending on the client’s need.
The kits include packaging material (styrofoam containers and corrugated shipping car-
ton, absorbent material, and press lock biohazard plastic bag), gloves (optional), documen-
tation (biospecimen submission form containing minimal information data, a shipping man-
ifest (Supplementary Data and Supplementary Fig. B.4), shipping checklist, shipping query
form, and a workflow on how to pack and ship the kit), and the specific biospecimen collec-
tion tubes that are already labeled. For example, a kit required for DNA and RNA sampling
might contain a 6𝜇𝐿 EDTA BD vacutainer or an 8.5 𝜇𝐿 PaxGene Blood DNA tube and a
10 𝜇𝐿 PaxGene Blood RNA tube or Tempus Blood RNA tubes depending on the down-
stream application. The kit assembly module provides the user the ability to select the ap-
propriate kit template such as the templates for DNA or RNA sampling, which in turn is used
to define the specific SOP required to assemble the material needed for the client’s project.
The kit template can be specific to one project or reused in different projects.
3.4.5 Shipping
The shipping module ensures that the correct instructions are given to send the appropriate
biospecimen containers (as packaged in the kits) to the client and subsequent email noti-
fication to alert the client of incoming kits. Similarly, an e-mail notification based on the
LIMS instructions will be sent to notify the NSB upon return of the kits from the client.
The NSB, in consultation with the client, defines the appropriate containers to ship to the
client and the shipping instructions to and from the client (Supplementary Data and Supple-
mentary Figs. B.4–B.7). The kit, assembled in a size-appropriate box (Supplementary Data
and Supplementary Fig. B.3), includes a manifest that describes each kit and the barcodes
(Supplementary Data and Supplementary Fig. B.4).
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3.4.6 Storage management
Biospecimen, kits, and stock items are handled within the inventory management module.
The inventorymanagement module describes the steps needed for the storage location so that
products can be ordered and stocks updated accordingly (Supplementary Data and Supple-
mentary Figs. B.8–B.14). Biospecimen storage covers a hierarchy of storage levels: storage
unit (or room), freezers, shelves, and boxes. The biospecimens are stored in cryoboxes in
various sizes depending on the size of the collection tube and cryotubes. For the other stor-
age types (kits and stocks), there is no hierarchy to respect and the positions can be created
at any level.
3.4.7 Freezer management
Different kinds of storage for biospecimens and aliquots exist inside the NSB depending on
biospecimen type as well as the need for short- or long-term storage. The freezer manage-
ment module describes the steps needed to define the structure that matches the physical
storage in the NSB: rooms (within rooms), freezers, shelves, cryoboxes, and positions/loca-
tions (Supplementary Data and Supplementary Figs. B.15–B.17). A freezer contains shelves
that contain cryoboxes. The last storage level at the NSB, namely cryoboxes, contains the po-
sitions reserved for biospecimens and aliquots. Similarly, the liquid nitrogen freezer and/or
dewar contain, respectively, racks that contain canes. The box and/or cane can have mul-
tiple positions for biospecimen storage. Three classes (content types) were used to design
the freezer management module (Supplementary Data and Supplementary Figs. B.15 and
B.18), namely storage unit (room), storage level (freezer, shelf, and cryobox), and storage
location (positions inside cryobox). This class inheritance was implemented using the object
database ZODB (www.zodb.org/en/latest).
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3.4.8 Security and administration management
Plone (the web-content management platform for Bika software) is based on the Zope frame-
work. Zope provides built-in security functionality that allows us to define roles with per-
missions. A “permission” controls whether logged-in or anonymous users with a specific
role can execute code and access contents. Each NSB staff member and client will have
specific assigned roles and a level of security. Baobab LIMS also inherits Plone’s secure
version-controlled document management system, Plone workflow system and audit trails
of back-end information changes made by the laboratory users.
Plone uses ZODB to store user data. ZODB, compared with SQL-based databases,
is not vulnerable to injection as it uses binary format that cannot have user data inserted
(www.plone.org). Plone authenticates users in its own database using a salted secure hash
algorithm (SSHA) of their password. Using its modular authentication system, Plone can also
authenticate users against common authentication systems such as LDAP as well as any other
system for which a plugin is available (Gmail, OpenID, etc.). After authentication, Plone
creates a session using an SSHA hash of a secret (token) stored on the server, the userid, and
the current time. This is based on the Apache auth tkt_cookie format, but with a more
secure hash function (www.plone.org).
3.4.9 Analysis request
A global list of available analyses is defined by the capabilities of the biobank laboratory.
At the project level, analyses are defined for biospecimens based on the requirements of the
project, such as DNA and/or RNA extraction applied to blood samples, and the resulting
quality and purity results of the extracted DNA and/or RNA. Results of these analyses are
registered and reported to the client (Supplementary Fig. B.20). The data are imported into
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Baobab LIMS through an instrument interface such as the biodrop interface (Supplementary
Data and Supplementary Fig. B.21).
3.5 Discussion
High-throughput genetic tools allow researchers to rapidly analyze thousands of biospeci-
mens, as is common in consortia focused on population-based studies. In response, biobanks
have to carefully consider the appropriate IT infrastructure that canmeet the demands of large
genetics studies. The Baobab LIMS was designed as an open source alternative for use in a
resource-limited setting to meet the demands of increasing biospecimen collection.
During the development of Baobab LIMS, a new open source LIMS, Acquire, was pub-
lished with a focus on pathology biospecimens (Dowst et al., 2015). This tool integrates the
inventory management functionality of OpenSpecimen with modules specifically designed
to meet requirements of researchers in a pathology laboratory. However, tools such as Open-
Specimen do not handle the specific biobank activities of NSB, which includes supporting
prepackaging of biospecimen laboratory kits for clients (Fig. 3.1).
The establishment of centralized biobanks in Africa has drawn attention to the issues of
interoperability between biobanks and harmonization of terminology used by each biobank.
These concerns are not unique to African biobanks (ISBER, 2012). Data standards such as
MIABIS (Norlin et al., 2012) provide an ideal platform to integrate data among biobanks.
The advantage of using the same terminology across biobanks was demonstrated through
the development of the virtual Breast Cancer Campaign Tissue Bank (Quinlan et al., 2015).
Although a biobank catalogue is not currently available at NSB, we envisage a simplified
application programming interface (API) that would allow users to access summary infor-
mation using data stored in Baobab LIMS.
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Quinlan and co-workers, (2015), suggested an increased role of ethical boards, gover-
nance, accreditation bodies, and funders to ensure that groups being authorized to collect
samples have sufficient informatics capabilities to ensure the samples are used (Quinlan et al.,
2015). This suggestion ensures that teams authorized to collect samples will also have the
technical skills to ensure that the associated data are managed correctly. This concept re-
lates to issues of biobank sustainability. Technical costs at a biobank go beyond supporting
a LIMS and instead should incorporate a biobanking informatics management system that
allows the biobank flexibility to meet the growing technical demands of making data avail-
able to a wider scientific community beyond biospecimen handling in a laboratory. In this
context, and doubling the cost suggested by Dowst and co-workers, (2015), for maintaining
their Acquire LIMS, the cost of employing a Linux administrator (20% full-time equiva-
lent [FTE]), database administrator (10% FTE) and a computer programmer (25% FTE) in
a South African setting would be 30,000 U.S. dollars (Dowst et al., 2015). The demands
placed on IT staff require that biobanks have dedicated staff for these technical roles, thereby
increasing personnel costs at least fivefold. These costs are a key consideration for centraliz-
ing and harmonizing biobanking in Africa. Unfortunately, local, regional, and international
funders need to appreciate the importance of this critical component required for modern
biobanking and the academic advantage of interoperability across evolving biobanks.
The adoption of Baobab LIMS by a wider user community will require more generic
and configurable workflows. Nevertheless, Baobab LIMS has become a central component
in the eB3Kit of the B3Africa project and is also included in the BBMRI-ERIC software
catalogue, and in the open BIBBOX application store (Müller et al., 2017).
Baobab LIMS website: https://baobablims.org/
Source code: https://github.com/BaobabLims/baobab.lims.git
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Online documentation: https://baobab-lims.readthedocs.io/en/latest
Online demo: http://baobab-demo1.sanbi.ac.za/. Use admin as username and password.
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Chapter 4
Baobab LIMS. A practical evaluation
exercise in a human biobank
4.1 Abstract
Laboratory Information Management Systems (LIMS) are valuable tools for automating and
managing biobank operations. However, it is often a complicated endeavour to find a LIMS
that incorporates and satisfies all possible workflow requirements that various biobanks may
utilise. In this regards, software testing helps in the mapping of user requirements to the
software functionalities, and furthermore, it may reveal new user enhancements and func-
tionalities. The tracking of changes in the requirements early in the development stages helps
to avoid development process delays and the exhausting of funds which, when they occur
may subsequently result in project failure. In this study, we present a tangible practical test
of the open source Baobab LIMS in a small scale biobank, namely NSB. The study demon-
strates the importance of such an exercise for software enhancement and the influence of
such enhancements on biobank sustainability.
http://etd.uwc.ac.za/
4.2 Introduction 49
4.2 Introduction
The Bridging Biobanking and Biomedical Research across Europe and Africa
(www.b3africa.org) is an EU-funded program. The B3Africa initiative aims to facilitate
scientific research collaborations between African and EU States, to provide an ethical and
legal framework to enhance mutual exchange of biospecimens and associated data, and to
release an informatics platform, the eB3Kit, containing a variety of biobanking and bioin-
formatics tools to support research activities (Slokenberga et al., 2017).
To meet the above objectives, 8 work packages (WP) were created (Fig. 4.1), each of
which was assigned predefined project deliverables (Table 4.1).
Fig. 4.1 B3Africa work packages. Each of the 8 work packages was assigned
predefined deliverables. WP3was responsible for the implementation of an open
source LIMS for the management of human biobanks (www.b3africa.org).
In addition to the mentioned work packages in Table 4.1, associate (beta) sites formed
part of the development process of certain deliverables. The associate sites were estab-
lished to assist in the design, conception and testing of concept aspects of certain deliver-
ables work packages were responsible for. For example, for Baobab LIMS development,
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Table 4.1 A brief description of the deliverables of each work package in the B3Africa
project (www.b3africa.org).
Work package Description
1 Provides a framework of legal and ethical regulations, which
enable biobank biospecimen and data sharing
2 Creates the technical framework for integration of open source
tools and hardware to be used in biobanking and bioinformatics
research studies
3 Develops and provides a Laboratory Information Management
System (LIMS) to be integrated into the platform (WP2) and
used in the proof of concept (WP7). The Baobab LIMS is the
final deliverable by the South African National Bioinformatics
Institute (SANBI), responsible of the WP3
4 Provides the bioinformatics framework for the B3Africa project.
It will provide guidelines for the implementation of
bioinformatics analysis pipelines, use and reuse of experimental
omics data, and sharing of datasets and results
5 Develops and implements a package for education and training
on the use of the platform, best practices in biobanking,
bioinformatics data analysis, and data sharing, observing ethics
and regulations
6 Disseminates knowledge about the B3Africa project, the
B3Africa informatics platform, and the possibilities it will
provide for biobanks and research groups in Africa and Europe
7 Implements a platform as a proof of concept. Several partner
institutions will take part as use cases to test the harmonization
of ethics and regulations, biobanking best practices (LIMS in a
Box), bioinformatics pipelines, and education and training in the
B3Africa platform
8 Deals with the day-to-day project management issues (strategic,
financial and legal, innovation, coordination of Work Packages,
quality and risk management) by the Project Coordinator and the
Project Manager
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WP3 worked closely with the NSB situated within the National Health Laboratory Service
(NHLS) and Stellenbosch University (SU) at Tygerberg Hospital. The NSB is an example
of a growing biobank, storing human biospecimens, and initially established as part of the
H3Africa project, funded by the US National Institute of Health (NIH) and the Wellcome
Trust, to facilitate studies on Health, Disease and Pharmacogenomics of African Populations
(https://www.sun.ac.za/english/faculty/healthsciences/haematological_pathology/biobank).
The NSB had initially not been using a LIMS to assist with the tracking of information
and, as such, had evaluated OpenSpecimen and Bika LIMS. However, both systems were
found to be unsuitable for their biobank operations. Baobab LIMS, an open source laboratory
information management system, was therefore designed and developed by following the
requirements and workflows of the NSB (see Chapter 3) (Bendou et al., 2017).
To this end, the workflow requirements of the NSB were translated into programming
modules that constitute the core of the Baobab LIMS software, and the design of the mod-
ules was performed in conjunction with the biobanking team situated at NSB. Following
development of each module, a series of tests and demonstrations were presented to the
NSB team in order to evaluate whether the module functionalities met the specified require-
ments of the biobank. Each module was subsequently restructured according to the feedback
obtained, retested and demonstrated to the NSB team. The cycle of feedback, software up-
dates, and tests was repeated until no further recommendations were made, and the module
functionalities met the biobank specifications. The development of the Baobab LIMS fol-
lowed the waterfall methodology for the first version but due to the increased interest in
the LIMS, the Baobab team has expanded to include a full time software developer and a
project analyst, and the next version of the software will be developed using an Agile scrum
methodology (Sliger, 2011). Sprints and milestones will be incorporated into the agile man-
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agement system and will be invaluable in the development processes related to innovative
requirements from biobanks.
System testing is described by the National Institute of Standards and Technology (NIST)
as “the validation that the software meets its requirement. Validation of the complete system
may involve many tests involving all system components. The software system tests exercise
those system functions that invoke software to determine whether the software behaves as
intended relative to complete system performance” (Klein, 2003). Furthermore, the Institute
of Electrical and Electronic Engineers (IEEE) described acceptance testing as the operation
that “checks the system behaviour against the customer’s requirements (the ‘contract’); the
customers undertake (or specify) typical tasks to check their requirements” (Klein, 2003).
The testing of any system is therefore vitally important to embark on, prior to the implemen-
tation of the system.
To investigate the ability of the developed Baobab LIMS to be used in automation and
tracking of human biobank operations, the final product was implemented at theNSBbiobank
and the full functionalities were tested and evaluated in a practical exercise.
4.3 Methods
a. Test scenario
The organisational structure of the laboratory-based personnel working at NSB comprises
of a lab manager, an IT system administrator, a lab clerk and two analysts. Throughout this
exercise each user was assigned specific roles and tasks in the LIMS (Table 4.2). A labora-
tory in the Division of Human Genetics at the University of Cape Town is one of the NSB
clients. The laboratory client accepted to participate in the LIMS evaluation, and a project
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entitled “Baobab test case” was agreed between both the lab managers. The client, for the
purpose of this defined project, is assumed responsible for the collection of whole blood
specimen from two “mock” participants. It is important to note that the intention of this
exercise was to evaluate the ability of Baobab LIMS to automate and track the information
of the biobank and client operations. Therefore, to facilitate the progression of the exercise
and avoid ethical and legal constraints regarding use of human specimens, the collection of
whole blood biospecimens were replaced with other non-human substances. Consequently,
there was no physical testing of the quality of the biospecimens. However, the information
was entered into the LIMS in order to ensure that tracking of analysis would have occurred
and been recorded appropriately, had the biospecimens been of human origin. The biobank
assembled two kits, one kit per participant, each containing two barcoded ’BD EDTA’ va-
cutainer tubes (Fig. 4.2(a)). The assembly process for each kit utilised products from the
inventory storage. Both kits were packed according to IATA regulations and enclosed in
a secure box, and subsequently shipped to the client using the DHL courier services (Fig.
4.2(b) and 4.2(c)). The client received the shipment. The standard workflow involves the
shipment received by the client and subsequent collection of biospecimens from consented
research participants. Thereafter, the biospecimens are dispatched back to the biobank using
one of two possible methods; either by notifying the biobank to send a preferred courier to
fetch the kits, or use the resources of the client for the dispatch. In the case of this exercise
with non-human substances, the former option of dispatch back to the biobank was utilised
following email notification sent from the client, to arrange for shipment collection. The
NSB then received the kits and ascertained whether all vacutainers and corresponding doc-
umentation are in place. As a standard, for the assigned workflow, DNA extraction analysis
followed by DNA purity and concentration assessment, as well as functional PCR would be
performed to determine the quality of the biospecimens. In the case of this exercise, dummy
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data were used as results of the biospecimen quality analyses, in accordance to the biobank
SOPs. Finally, the biospecimens were stored in positions reserved in the biobank freezers.
Table 4.2 A list of roles and tasks assigned to each of the NSB biobank personnel.
User role Tasks
IT system
administrator
Install LIMS, create a clean Baobab site, manage the system,
and create users with roles
Lab manager Conclude agreement with the client, create project and specify
the biospecimen types and analyses to be done to the client’s
biospecimens, and review analysis reports
Lab clerk Manage biospecimen and inventory storage, make supplier
orders, and assemble kits
Lab analyst Create analyses, analyse biospecimens, and capture results
b. Data capture
The Baobab LIMS used during the evaluation exercise, was installed in a
“built-to-specification” standalone personal computer (PC) hosted at the South African Na-
tional Bioinformatics Institute (SANBI). The operating system for the PCwas Ubuntu 16.04,
whose official support is guaranteed until April 2021. The PC station was characterised by
the following features; 32GB Random Access Memory (RAM) and 2TB disk space. Access
to the machine from outside the SANBI network is restricted by a firewall and, as such, only
the web server is accessible.
A clean Baobab site, named NSB, was created to track all possible information that could
be extracted from the above test scenario. Baobab LIMS allows for the creation of more than
one site in a Baobab LIMS installation, with each site having its own users and information.
This may be important to a biobank with peripheral collection sites, and instead of imple-
menting Baobab LIMS in every collection site, the LIMS application can be installed, for
example, in the biobank IT infrastructure, and for each collection site an individual Baobab
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(a) (b)
(c)
Fig. 4.2 (a) Kit assembly process. The kit contains two empty barcoded tubes aimed to
contain whole blood specimens. (b) The shipment containing the kits is ready to dispatch.
(c) Waybill showing the courier information and both biobank and client addresses.
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LIMS site can be created. The online user manual documentation was used as a reference
guide during the data entry process (https://baobab-lims.readthedocs.io/en/latest/).
The interaction with the LIMS application began with the creation of the biobank and
client users by the IT administrator. Roles, permissions and login access information were
assigned to each user. The lab manager added a new project with all necessary information
such as project title, description, number of participants, biospecimen types and analyses to
perform on the client biospecimens. Inventory management, freezer management and order
supply were responsibilities of the lab clerk. The user created ’BD EDTA’ vacutainer as
“Product” and placed an order for product supply. The quantities received were assigned
to each product in the system and using the kit assembly module, the lab clerk added two
kits with the two empty tubes. Automatic barcodes were assigned to the two tubes and were
recorded in the LIMS by using the barcode scanner. A shipment record containing the two
kits was added by the lab clerk. Additional information such as courier, client address and
shipping dates were also provided in the shipment record. An automatic email was gener-
ated notifying the client of a possible arrival of the specific shipment from the biobank. The
client used the LIMS features to acknowledge, via email, receipt of the shipment, and to no-
tify the biobank, also via email, of the end of the process of collection. At the receipt of the
biospecimens by the biobank, the lab analyst added the analyses and results of the biospec-
imen quality checks into the LIMS. The biospecimens were assigned storage positions in a
freezer box that the lab clerk had created previously. The lab manager verified the results
and generated an automatic LIMS report which was then sent as an email attachment, to the
client.
c. Evaluation
The NSB group evaluated the laboratory information management system from different
perspectives; (1) the workflow implementation covering the life cycle of a biospecimen from
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creation to complete use or destruction, (2) security and administration management, and
(3) LIMS components; kit assembly, shipping, analysis request and freezer management. A
simple method based on a numbering system from 1 to 5, with 1 being very bad and 5 being
excellent, was used during the assessment of the Baobab LIMS performance (Table 4.3).
Table 4.3 A simple evaluation method based on a numbering system from 1 to 5, with 1
being very bad and 5 being excellent.
Value Description
1 Very bad
2 Bad
3 Satisfactory
4 Good
5 Excellent
d. Additional evaluations
Following the NSB practical exercise, and to further demonstrate the strengths and weak-
nesses of the Baobab LIMS functionalities, similar evaluations were requested from, and
carried out by Institut Pasteur de Tunis and Uganda biobank. Due to the fact that the Institut
Pasteur de Tunis Biobank used the online documentation to install, setup and use in a produc-
tion environment Baobab LIMS, the online documentation was included in the assessments.
Conversely, the Uganda Biobank technicians were trained in a face-to-face training session
prior to LIMS utilisation.
4.4 Results
a. NSB evaluation
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Table 4.4 summarises the results of the evaluation. All aspects were evaluated with
respect to the numerical indicators (Table 4.3). The results of the NSB evaluation demon-
strated that the LIMS performance did not score below 4 for any aspects evaluated (Ta-
ble 4.4). One issue was reported with regards to the online user manual guide. The lab
manager commented that the online documentation was “very useful for an experienced
LIMS user but could be daunting for a novice user”. The lab clerk, suggested an enhance-
ment functionality to support the storing of photographs of kits and/or individual barcoded
biospecimens as they were shipped and received back from clients, for quality assurance
and quality control (QA/QC). He also raised concerns regarding the freezer management
component, suggesting that it can be difficult for novice users and proposed that more de-
tails pertaining to the module should be elaborated on, in the online documentation. The
lab analysts further suggested that the addition of deviation codes (such as empty tubes, low
volumes, cracked tubes) to biospecimens in a QC module would be beneficial. The docu-
mentation has since been updated, and ongoing work is in progress to add video tutorials
for novice users. The other suggestions have been created as issues in the github repository
(https://github.com/BaobabLims/baobab.lims) and will be addressed in subsequent versions.
Some screenshots from the LIMS user interface have been provided in the Appendix B.
b. Institut Pasteur de Tunis and Uganda biobank evaluations
Tables 4.5 and 4.6 indicate the evaluation results from Institut Pasteur de Tunis and the
Uganda Biobank, respectively. The Institut Pasteur de Tunis biobank scored the online doc-
umentation a ‘4’ and suggested to provide more detail on certain steps within the documen-
tation. Two issues were raised regarding Kit assembly related to encoding problems (Use
of French special characters) and adding kits without registering a study project. Another
issue pertaining to the Freezer management module was noted, in that reagents could not
be added to freezer shelves. Furthermore, one issue concerning the upload of user man-
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Table 4.4 Scores and issues of the evaluation of the Baobab LIMS modules by the NSB
biobank users.
Component Description Evaluation (1-5) Issues
Workflow
implementation
Biospecimen “life cycle” coverage,
from collection to destruction, and
the collection of key information
such as the time the biospecimens
arrived in the laboratory, company
delivered, time and who
accessioned biospecimens, the user
that performed the analysis and the
time of completion of the task
4 The one problem
is that the online
manual can
create problems
for a novice user
Security and
administration
management
Each NSB staff member and client
will have specific assigned roles
and a level of permission and
security
5 No issues
detected
Kit assembly This component provides the
protocol needed to assemble kits
that will be used to collect
biospecimens in the field
5 No issues
detected
Shipping The module ensures that the
correct instructions are given to
send the appropriate biospecimen
containers (as packaged in the kits)
to the client and subsequent email
notification to alert the client of
incoming kits
4 We have tested
this module with
our laboratory
client and the
processes were
efficient
Analysis request At the project level, analyses are
defined for biospecimens based on
the requirements of the project.
Results of these analyses are
registered and reported to the client
5 No issues
detected
Freezer
management
The module describes the physical
storage in the NSB: rooms (within
rooms), freezers, shelves,
cryoboxes, and positions/locations
4 Documentation
may confuse
novice user
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ual documents for laboratory instruments which were added in the Baobab LIMS, was also
observed. The former concern with the instrument module was not included in the evalu-
ation process, however, the users did bring this to the attention of the Baobab LIMS team
during evaluation. The shipping and analysis request modules are not a requirement for the
biobank, and as such, are marked as “Not applicable”. Similarly, Uganda biobank assessed
the Baobab LIMS online documentation as “4” and raised an issue regarding Plone depen-
dency problems during the installation of the LIMS in a new Ubuntu 18.04 server machine.
All the remaining modules were assessed by the Uganda biobank team as “5” (Excellent).
The issues raised by Institut Pasteur de Tunis and Uganda Biobank are discussed in the next
section.
4.5 Discussion
The NSB evaluation exercise was beneficial for both the biobank and the LIMS developers.
The biorepository group experienced an alternative method, which was automated, organ-
ised and secure, in contrary to practices such as the utilisation of spreadsheets, which create
risks associated with being stored in different locations, being accessible and easily edited by
users without restrictions, and generating file versioning inconsistencies and potential loss
of information. For the system developers there was a level of anticipation to see all com-
ponents of the LIMS tested for the first time in a small biobank. The developers followed
the exercise from the beginning to the end and as such, were on-hand for the possibility
and appearance of unexpected bugs. Fortunately, the abovementioned did not occur, and all
the LIMS components worked efficiently. The exercise demonstrated the ability of Baobab
LIMS to be used in themanagement practices related to biobank information. In addition, the
evaluation exercise revealed the importance of user feedback in the enhancement of certain
modules, and the expansion of the LIMS with new functionalities. It is noteworthy to men-
http://etd.uwc.ac.za/
4.5 Discussion 61
Table 4.5 Scores and issues of the evaluation of the Baobab LIMS modules by the Institut
Pasteur de Tunis biobank users.
Component Description Evaluation (1-5) Issues
Online
documentation
The online documentation
(http://baobab-
lims.readthedocs.io/en/latest/) used
to install, setup and use Baobab
LIMS
4 Certain described
steps need more
details
Workflow
implementation
Biospecimen “life cycle” coverage,
from collection to destruction, and
the collection of key information
such as the time the biospecimens
arrived in the laboratory, company
delivered, time and who
accessioned biospecimens, the user
that performed the analysis and the
time of completion of the task
4 No issues
detected
Security and
administration
management
Each NSB staff member and client
will have specific assigned roles
and a level of permission and
security
4 No issues
detected
Kit assembly This component provides the
protocol needed to assemble kits
that will be used to collect
biospecimens in the field
3 Problem with
special characters
(encoding) and
we cannot add
kits without
having a project
Shipping The module ensures that the
correct instructions are given to
send the appropriate biospecimen
containers (as packaged in the kits)
to the client and subsequent email
notification to alert the client of
incoming kits
Not applicable
Analysis request At the project level, analyses are
defined for biospecimens based on
the requirements of the project.
Results of these analyses are
registered and reported to the client
Not applicable
Freezer
management
The module describes the physical
storage in the NSB: rooms (within
rooms), freezers, shelves,
cryoboxes, and positions/locations
3 We cannot add
reagents in shelf
of refrigerator
http://etd.uwc.ac.za/
62 Baobab LIMS. A practical evaluation exercise in a human biobank
Table 4.6 Scores and issues of the evaluation of the Baobab LIMS modules by the Uganda
biobank users.
Component Description Evaluation (1-5) Issues
Online
documentation
The online documentation
(http://baobab-
lims.readthedocs.io/en/latest/) used
to install, setup and use Baobab
LIMS
4 Dependencies
libxslt and libxml
posed a very big
problem to the
Plone installation
Workflow
implementation
Biospecimen “life cycle” coverage,
from collection to destruction, and
the collection of key information
such as the time the biospecimens
arrived in the laboratory, company
delivered, time and who
accessioned biospecimens, the user
that performed the analysis and the
time of completion of the task
5 No issues
detected
Security and
administration
management
Each NSB staff member and client
will have specific assigned roles
and a level of permission and
security
5 No issues
detected
Kit assembly This component provides the
protocol needed to assemble kits
that will be used to collect
biospecimens in the field
5 No issues
detected
Shipping The module ensures that the
correct instructions are given to
send the appropriate biospecimen
containers (as packaged in the kits)
to the client and subsequent email
notification to alert the client of
incoming kits
5 No issues
detected
Analysis request At the project level, analyses are
defined for biospecimens based on
the requirements of the project.
Results of these analyses are
registered and reported to the client
5 No issues
detected
Freezer
management
The module describes the physical
storage in the NSB: rooms (within
rooms), freezers, shelves,
cryoboxes, and positions/locations
5 No issues
detected
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tion that many functionalities are commonly used in a multitude of biobanks, and as such, an
enhancement feedback from a unique biobank may benefit other biorepositories sharing the
same requirements, as well as those which may expand to incorporate such functionalities
as they grow and evolve.
According to Davis and Venkatesh, (2004), the high rate failure which occurs in com-
plex software development is caused during the requirements management processes and is
greatly due to lack of user input, incomplete requirements and changing requirements (Davis
and Venkatesh, 2004). By including the NSB team from the early development stage, partic-
ularly with regards to the design of the Baobab LIMSmodules, a successful software product
which caters to the outlined biobank requirements, was created. At the end of each module
development, the module functionalities were demonstrated to the end users. The demon-
strations aided with increasing the user feedback whereby partially met and/or changes in
the requirements were instantly tracked. Consequently, the LIMS software was delivered in
the desired time, and ultimately, the test of the complete product functionalities described
above, were evaluated with the best scores.
Baobab LIMS meets the needs of a biobank and in the above test case, it was demon-
strated that the different modules are ideally suited to the functions of a small-scale biobank.
A number of valuable improvements have been identified in this evaluation exercise and
forms the basis of a new specifications for the next version release of Baobab LIMS. The
suggested improvements concern the QA/QC module and the online documentation.
The QC modifications suggested by the biobank users are (1) new functionality to store
photographs of assembled kits on the system at two separate times, before shipment and
reception back from a client, to determine packaging damage and/or proof of arrival and
acceptance into biobank as well as distribution, and (2) QC enhancement by adding devi-
ation codes to biospecimens in case of handling issues and assigning function of process
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and/or storage. As it is possible that throughout the overall process a kit or a biospecimen
container may be damaged, or a biospecimen may fail initial acceptance and rejection cri-
teria. In these cases, it is vitally important to capture this information as it will determine
whether biospecimens will be accepted, rejected or flagged. This will have an effect on the
final destination of the biospecimen especially for those that have been rejected and sub-
sequently not processed and stored even though initial capture had occurred in the LIMS.
In this way, pictures of kits and biospecimens taken before shipment, and following receipt
from a client, allows for visual identification of the possible step which may have resulted
in the operational procedure failure. Furthermore, a deviation code can be assigned to a
biospecimen which precisely defines the cause of biospecimen rejection, such as, a miss-
ing biospecimen, a broken biospecimen, or a biospecimen of insufficient volume, to cite a
few possibilities. The suggested improvements to QC are of value and importance to aid in
the identification of error-prone operating procedures and as such, will affect decisions to
enhance the procedures or to replace them with harmonized operating procedures (SOPs).
Adherence to best practices and SOPs, from a national and/or international specialised or-
ganisation such as the International Society for Biological and Environmental Repositories
(ISBER), may dramatically improve the quality of annotated biospecimens and the perfor-
mance of biobanking services. Tools such as the ISBER online self-assessment tool helps
biobanks to determine how well they follow the ISBER best practices and identify areas that
need improvement. The self-assessment exercise is an important undertaking and should be
performed before applying for certification and/or accreditation to International Standards
Organisation (ISO) (ISO 20387 general requirement for biobanks currently under review)
and certification programs such the College of American Pathologists (CAP) Biorepository
Accreditation and the CTRNet Biobank Certification Program (Betsou, 2017). Certification
and accreditation are regarded by external bodies (funders, researchers, ethics committees)
as a proof of professionalism and ensures quality products and services by the certified and/or
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accredited biobank, and may therefore increases the biorepository usability and sustainabil-
ity by attracting more users and funders (Barnes et al., 2016). Additionally, compliance to
standards and adherence to best practices ensures that biospecimens originating from dif-
ferent accredited biobanks, to be used in a collaborative research study, are comparable in
quality and exhibit reduced preanalytical variability. These combinatorial factors thereby
provide high assurance of accuracy, reproducibility and comparability of the research re-
sults (Betsou, 2017).
With regards to the second area of concern described by the NSB, the original online
LIMS instructional documentation was “difficult and confusing for a novice user”. The
documentation used during the test exercise was written in a single PDF document. It is
however understandable that placing all the LIMS information in one file may overwhelm
readers. The updated online documentation is nowwritten with Sphinx, (http://www.sphinx-
doc.org/en/master/), a tool that makes it easier to create logical and visually appealing on-
line documentation, in the format of an interactive website, with a possibility of integrat-
ing tutorial videos. The documentation was subsequently restructured and re-organised
into 3 parts; the installation manual, the setup manual and the user manual, and in so do-
ing, has made the documentation clearer, easier and more understandable (https://baobab-
lims.readthedocs.io/en/latest). The new version of the online documentation was evaluated
as “4” (Good) by both Institut Pasteur de Tunis and Uganda biobank. However, parts of
the documentation remain unclear to users and needs to be explained in more detail. For
example, the users in the Institut Pasteur de Tunis biobank were not able to store reagents
using the freezer management module, however, this is indeed possible in Baobab LIMS.
Furthermore, including warnings of dependency conflicts in the documentation will avoid a
long debugging process, which occurred in the case of the Ugandan users, who attempted
to install Plone in a not-yet supported newly released Ubuntu version. Nevertheless, the
improved documentation can itself be used for self-training of a user, as demonstrated by
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the Institut Pasteur de Tunis biobank, who successfully implemented Baobab LIMS in a
production environment using particularly the online documentation. Enhanced and proper
documentation therefore decrease the need for recurrent face-to-face training sessions which
requires individuals to travel to the respective sites and would therefore reduce this particular
costs for the biobank. This can be of particular application for biobanks with already limited
resources. The enhancement of the online documentation and the subsequent reduction in
employee learning curve can therefore assist in reducing expenditures and ultimately increase
user productivity and biobank sustainability (Lynch and Buckner-Hayden, 2010). However,
training sessions of sufficient time periods do assist users with a better understanding of the
LIMS functionalities and the applicability of these functionalities to their specific biobank
workflows. The observed impact of training users was demonstrated by the scores of “5”
(Excellent) from the Uganda biobank for all of the Baobab LIMS functionalities evaluated.
Other issues raised during the evaluation, in particular by the Institut Pasteur de Tunis
biobank, included text encoding and document storage. The text encoding issue raised by
the Institut Pasteur de Tunis biobank is related to language interpretation by Baobab LIMS.
Consequently, the LIMS may not accept non-ASCII characters, such as French special char-
acters. There is ongoing work to translate Baobab LIMS and its online documentation into
French, and use unicode encoding to accept non-ASCII characters. Translation of Baobab
LIMS into other languages will help non-English speaking users to decrease the learning
curve and therefore quicken the use of the LIMS. Baobab LIMS provides users options for
storing and linking file documents, such as user manuals for laboratory instrument records
created in the LIMS. However, this functionality remains a basic one when compared to
specialised document store tools. Progress in this area is the responsibility of WP2, with
BIBBOX (a platform of open source applications) already integrating Baobab LIMS and
tools for document storage, such as the SeedDMS (https://www.seeddms.org). Other po-
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tential problems which have surfaced during the different evaluations, have been created as
Github issues and will be addressed in future Baobab LIMS versions.
As previously mentioned, sustainability is the biggest challenge facing biobanks which
operate under resource limitations (Abayomi et al., 2013). As such, open source LIMS may
support biobanks in sustaining their operations by reducing the prohibitive cost associated
with commercial LIMS in terms of license fees, implementation, support and training, and
customisation (Kyobe et al., 2017). Furthermore, given the fact that practices vary depend-
ing on the type and scale of biobanks (Malm et al., 2013), customisation of LIMS may apply
to other biobanking practices. The open source aspect of Baobab LIMS allows for customi-
sation of the source code by in-house biobank IT software developers with new modules
specific to their biorepositories. Furthermore, the continued development of Baobab LIMS
by the principle developers creates an environment whereby a community of engaged de-
velopers can be formed and possibly work together to contribute significant enhancements,
ultimately aiding in the value and extended usability of a more universal LIMS.
4.6 Conclusion
Evaluation exercises of a final software product by the customer (laboratory, or company)
allows alignment of user requirements to the software functionalities, discovery of addi-
tional enhancements and new functionalities (that may be of great interest for customer),
and also to improve robustness of the software functionalities. The evaluation exercise of
Baobab LIMS at the NSB biobank allowed for discovery of two major enhancements that
are indirectly related to the sustainability of the biobank; QC and online documentation.
Following the success of the evaluation test, the LIMS was also demonstrated and tested in
other biobanks in Tunisia and Uganda. Interestingly, the biobank team at the Institut Pasteur
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de Tunis, was able to successfully install, test and start utilising the Baobab LIMS in a pro-
duction environment by exclusively utilising the improved online documentation, thereby,
demonstrating the importance of this resource in training and LIMS implementation. Other
suggestions and valuable enhancements were obtained from the above mentioned testing in
other biobank cases, and are discussed in the next chapter 5; Conclusions and further con-
siderations.
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Conclusions and further considerations
The majority of laboratory information management systems (LIMS) is either developed for
(1) in-house use, which can possiblymake customisations for other biobanking scenarios dif-
ficult, (2) commercial sale at higher prices, although, they may not be efficient, or (3) open
source sharing code but, unfortunately, they could be missing essential functionalities. The
B3Africa consortium undertook the decision to incorporate an open source LIMS, which is
robust, easy to use and customisable. In this thesis Baobab LIMS was developed following
an evaluation by stakeholders, and with the aim to automate state-of-the-art biobank opera-
tions. One of the motivations for developing this tool was to address the lack of open source
LIMS which integrates maximum functionalities required by modern biobanks. The exis-
tence of such a biobanking tool in themarket, that is rich in functionalities, well-designed and
free of license fees, is of great value for biobanks, and particularly for those which operate
under limited resources in low and middle income countries, specifically on the African con-
tinent. A possible consequence of a profusion of a high quality open source LIMS may force
commercial LIMS companies to review their prohibitive pricing strategies. Furthermore,
competition between companies prevents monopoly of the market and may drive innova-
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tive solutions at lowered costs. Therefore, it would benefit biobanks in the selection of an
appropriate LIMS which meets the desired requirements, at lower cost.
By including the NSB team in the early stage development process of Baobab LIMS
modules, the biobank requirements were clearly defined. Testing of the LIMS modules at
different stages of the development was undertaken, and a system with valuable functional-
ities for human biobank automation was successfully delivered in the required time frames
(see Chapter 3). The LIMS adheres and follows the ISBER guidelines and best practices for
repository information management system (Campbell et al., 2018; Kyobe et al., 2017), and
some of the valuable core functionalities are outlined below;
Authentication and authorisation: Baobab LIMS is implemented using Plone
(https://plone.org/), a secure and robust Python framework. Plone has been utilised by rep-
utable organisation such as FBI, NASA, Amnesty Internation and other well-known compa-
nies (http://plone.com/images/logo-companies-that-use-plone/view). Baobab LIMS inherits
Plone securitymodules thereby allowing for the creation of groups of users, with permissions
and roles assigned to each group.
Client - linked project registration: Collection of biospecimens can only be done within
a specific project, defined by the biobank and the client. Client and project information are
tracked in the LIMS.
Inventory management and supply orders : The system allows for the creation of prod-
ucts, placing orders with suppliers, and tracking product quantities.
Kit assembly: The process uses available quantities of products in stock and the LIMS
tracks kits and products, as well as the quantities used.
Kit shipment: The shipments to, and /or from clients during biospecimen collection is mon-
itored and logged in the system.
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Biospecimen registration: Manual entry of new biospecimens, and the creation of batches
of samples are both possible in Baobab LIMS. Furthermore, Baobab LIMS is MIABIS com-
pliant and allows for biospecimens to be linked to anatomical collection site, disease ontology
and donor information. With regards to donor information, regulations such as the GDPR
which is related to privacy and participant data minimisation have been carefully considered.
Freezer management: Biospecimen storage is represented in the system as a hierarchical
tree with the possibility of creating infinite levels of storage. Therefore, it is possible to
find the exact position of a biospecimen in a storage system, for instance, the room, freezer,
shelf, rack, box, and position in which a biospecimen is located. The “position” hierarchy
is listed in a table and visualised in a 2D graphical representation, making it easier to locate
the biospecimen.
Laboratory analyses: Clients can request for an analysis to be performed on a selected
biospecimen if the service is offered by the biobank in question. The analysis information
and the results obtained can be captured in the LIMS.
Report generation: Results from analyses can be automatically generated and sent to dif-
ferent stakeholders such as clients, laboratory managers, and/or third parties.
Log audit: Baobab LIMS uses ZODB database for back-end information storage. Records
are stored as objects, and for each object type, a workflow is assigned. Transitions to a
new state are automatically logged in the system. For example, chain-of-custody such as
which user triggered the transition, and the date when the transition occurred is recorded.
Therefore, inconsistencies in the database information can be audited. Corrective actions
regarding these inconsistencies are then possible, either by manual editing of the affected
records, or by restoring information to the last back-up of the database. Furthermore, if
novice users to the system perform erroneous actions, log audit files will provide important
metrics and may elude to further training requirements.
http://etd.uwc.ac.za/
72 Conclusions and further considerations
Database backup and restore: Baobab LIMS provides two command lines for database
backup and restore; bin/backup and bin/restore, respectively. The backup of the database
is a vitally important operation to undertake regularly, and it allows the restoration of LIMS
information in cases where data is lost or corrupted.
In this thesis, we evaluated the developed Baobab LIMS modules in a practical test ex-
ercise. The evaluation demonstrated that the LIMS functionalities meet user requirements,
and no errors were detected. However, testing of the system revealed new enhancements
and functionalities, which the biobank users may not have originally been aware of. Inter-
estingly, the enhancements were not discovered at the first communication of the biobank
requirements or even at the separate module demonstrations, which motivates for testing of
the combined LIMS functionalities in one comprehensive exercise. Furthermore, the exer-
cise demonstrated the benefits of the suggested enhancements to the biobank, particularly
with regards to the LIMS online documentation. Similarly, the enhancements benefit the
LIMS software by increasing usability as, the changes may be valued by other biobanking
institutions (see Chapter 4). Performing similar testing with other biobanks has resulted in
the identification of two new enhancements, cited below;
Application Programing Interfaces (API) discovery
APIs are HTTP methods to obtain and update data recorded in the LIMS. The methods can
be run using an internet browser, a terminal command line (curl), or functions in a higher
level programing language (ajax function in JQuery). The API discovery module allows for
the discovery of a specific, or all possible APIs, provided by Baobab LIMS. The output of
the module is a json response containing information of what URI and parameters to use
in a CRUD (Create, Read, Update and Delete) operation. For each parameter, information
http://etd.uwc.ac.za/
5.1 Future considerations 73
such as name, type, and whether the parameter is required or optional, are shown in the json
response. The API discovery module was developed and released in Baobab LIMS version
1.4. With the module in place, it becomes easier and faster to find an existing API to integrate
into other programing applications.
Biospecimen shipment
In addition to extra shipments of biospecimens between biobanks and clients, the new en-
hancement will allow for intra-departmental shipments. These shipments may not require
special transfer via a courier, and as such, the transfer operation can be fulfilled by an in-
ternal agent, or “runner”. The module should track the transfer of a biospecimen between
departments, and the turnaround time to reach the subsequent destination. This tracking of
time information is necessary for quality control related to biospecimen integrity within the
bioank operation. The development of the biospecimen shipment module is in its final phase
and will be released soon in the next version 1.5 of Baobab LIMS.
5.1 Future considerations
Github provides metrics which present the number of clones, and number of views of the
source code by unique users. The metrics obtained thus far indicate a growing interest in
downloading the LIMS from the public github repository for testing (Fig. 5.1). Upon ini-
tial use of the LIMS, many laboratories and biobanks have requested availability of support
from the LIMS developers. As a result, proposals and grant applications have been investi-
gated to ensure user support availability for the future, and the creation and engagement of a
developer community for further developments and enhancements of Baobab LIMS which
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take into account new upcoming functionalities and technologies. Two projects are already
planned for the next development phase; android and IOS mobile application which will
assist in the capture of biospecimen information from collection fields that may not have
internet access. Once this data has been captured the information can be stored temporarily
in mobile device memories.The information transfer into Baobab LIMS can be done via API
technology when the internet connection is restored. This mobile application will help assist
laboratory technicians working in the field by reducing manual entry of the information in
paper form, thereby, reducing risks of human errors, and turnaround time, while increasing
security of data and information.
Fig. 5.1 Number of clones (downloads) and visitors, for a period of two weeks,
of the Baobab LIMS source code from unique users.
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The second sub-project is the workflow integration of Baobab LIMSwith Stategra Exper-
iment Management System (Hernández-de-Diego et al., 2014), and the Galaxy bioinformat-
ics workflow management system (Afgan et al., 2016)(Fig. 5.2). It has been found that 75%
of published clinical research including bioinformatics studies are not reproducible (Moore
et al., 2011) and as such, this project aims to reduce possible issues related to clinical re-
search reproducibility. Each of the abovementioned tools can be used by different groups
of users; Baobab LIMS by biobank users to enter biospecimen information, Stategra EMS
by laboratory technicians to enter information related to the experiments performed on the
biospecimens, and Galaxy by bioinformaticians to capture information regarding the down-
stream bioinformatics analyses performed on the biospecimen datasets generated in the ex-
perimental phase.
In this project, a catalogue to search by biospecimen, laboratory experiment and bioin-
formatic analysis, will also be developed. Therefore, for a specific biospecimen used in a
clinical research study, it will be possible to find the laboratory experiments performed, with
the exact parameters used, and the bioinformatics workflows utilised for the analysis of the
biospecimen dataset. By having access to this relevant information, reproducibility of the
results may no longer be a challenging endeavour.
To this end, the future work will ultimately assist in further biobank automation, increas-
ing productivity and quality of biospecimens. This will, consequently resulting in improved
accuracy of downstream analyses with the ultimate aim of ameliorating human health and
welfare.
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76 Conclusions and further considerations
Fig. 5.2A biobanking to bioinformatics workflow tool to track biospecimens and
associated data in clinical research.
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Appendix A
Baobab LIMS installation
The implementation of Baobab LIMS is based on Plone framework. Therefore, dependencies
needed by Baobab LIMS installation are mostly same dependencies required by Plone.
Plone Installation
Here we describe how to install Plone on Debian/Ubuntu 16.04 operating system. For an in-
stallation in a different operating system, check the Plone online documentation,
https://docs.plone.org/4/en/manage/ installing/installation.html. The installation process re-
quires users to have root privileges and basic knowledge of the Linux command lines using
a terminal. If you are not familiar with UNIX operating systems, read this tutorial Linux
shell https://maker.pro/linux/tutorial/basic-linux-commands-for-beginners. Please note that
a single line must be completed at a time.
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Plone dependencies
Plone framework requires the installation of additional system packages. Without these
packages installed, Plone will not compile.
$ sudo apt install build-essential gcc python-dev git-core libffi-dev
$ sudo apt install libpcre3 libpcre3-dev autoconf libtool pkg-config
$ sudo apt install zlib1g-dev libssl-dev libexpat1 -dev libxslt1.1
$ sudo apt install gnuplot libcairo2 libpango1.0-0 libgdk-pixbuf2.0-0
Download Plone Unified Installer
The Baobab LIMS is implemented and tested with Plone 4.3.11, a version released in 2016-
09-12. You can download Plone 4.3.x by visiting the Plone site https://plone.org/download.
Select and click on the Unified installer of your choice, or run the wget command line, in
your terminal, with the path to the Plone version to install. For this installation we are using
Plone 4.3.11;
$ wget --no-check-certificate https://launchpad.net/plone/4.3/4.3.11/
+download/Plone -4.3.11-r1-UnifiedInstaller.tgz
If the download has been done from the Plone site, the installer would be located in the
~/Downloads folder in the home directory. If the second option used i.e, the wget command
line, the installer should be downloaded into the current directory.
Install Plone
To continue the installation, in the terminal, change directory to the folder containing the
downloaded file then run the following command line to unpack the 𝑡𝑔𝑧 file.
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$ tar -xf Plone -4.3.11-r1-UnifiedInstaller.tgz
Change to the extracted folder in the terminal.
$ cd Plone -4.3.11-r1-UnifiedInstaller
Run the following command to install Plone
$ ./install.sh --target=/home/<ubuntu-user>/Plone --build-python zeo
where --target parameter is used to specify the path to the installation folder,
--build-python will add and build Python package in your system, (this is optional if
Python already installed) and finally zeo option will install Plone as a Client/Server appli-
cation. Plone requires Python2.7 in order to operate. Run ./install.sh --help to obtain
the full list of the available parameters and their meaning.
Install Baobab LIMS
In the new folder created /usr/local/Plone, another folder named zeocluster can be found.
This folder contains the configuration file buildout.cfg. Find in the configuration file the
section starting with eggs=, and add bika.lims and baobab.lims to the existing entries.
Note:
Bika LIMS is a dependency that Baobab LIMS needs to function. Some of the modules in
Baobab LIMS reference and import modules in Bika LIMS.
$ eggs =
Plone
Pillow
bika.lims
baobab.lims
http://etd.uwc.ac.za/
92 Baobab LIMS installation
Add to the section develop= the path to your version of Baobab LIMS and BIKA LIMS
that should be already downloaded into your local machine. By convention, it is preferable
to put the source code in “zeocluster/src” of your Plone installation folder.
$ developer =
src/baobab.lims
src/bika.lims
src/graphite.theme
Use git clone or fork this project to have your own copy in your local machine. For develop-
ers, any change in your source code that you judge interesting and useful for the community,
please create a pull request and let us know if you want to be part of the Baobab LIMS
community project.
$ git clone https://github.com/BaobabLims/baobab.lims.git
$ git clone https://github.com/BaobabLims/bika.lims.git
$ git clone https://github.com/BaobabLims/graphite.theme.git
Save the file, and run bin/buildout -n. Buildout will download and install dependencies
required by Baobab LIMS.
If you installed Plone as a root user i.e., using sudo, you should run the buildout command
line with the user plone_buildout, this user is automatically created during the Plone in-
stallation;
sudo -u plone_buildout bin/buildout
Warning:
If you encounter issues of type “Packages not found”, add the following line to the [buildout]
section in the buildout.cfg file.
index = https://pypi.python.org/simple/
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Test your installation
First, you will need to start the zeoserver, that is, the backend database server;
$ bin/zeoserver start
Thereafter, start one of the Plone clients in a debug mode, for this, run the following com-
mand;
$ bin/client1 fg
If you installed Plone as a root user, you will need to use the following commands instead;
$ sudo -u plone_daemon bin/zeoserver start
$ sudo -u plone_daemon bin/client1 fg
In your preferred browser, Firefox orGoogle chrome, run the following http://localhost:8080
to launch Baobab LIMS application.
If installed on a remote server, an IP address (of the server) is associated with the use of
LIMS eg; https://192.168.1.1:8080
In a production mode, other important tools need to be installed and configured,
such as Supervisorctl and Nginx. The following article,
https://docs.plone.org/manage/deploying/production/ubuntu_production.html details the pro-
cess to follow to add and configure those tools.
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Supplementary data
This supplementary document describes (with screenshots) each of themodules that were de-
veloped to produce the Baobab Laboratory InformationManagement System (LIMS) namely
(1) kit assembly, (2) shipping, (3) storage management, (4) inventory management, (5)
freezer management, (6) sample storage management, (7) biospecimen registration, and (8)
analysis request (AR) by a client.
Kit Assembly
The following kit attributes are maintained with a kit template;
• Component list (select from components available in the database)
• Quanity of each product in a kit
• price of a kit based on the price of the kit products and VAT
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The submission sites (the biobank’s clients) order kits from the biobank based on a par-
ticular project to be carried out on a specific case study. For example, blood samples are
to be collected to carry out DNA extraction and subsequent analysis on a group of partici-
pants. The laboratory manager navigates to “Kit assembly” form and selects from a list of
prepacked/designed kit templates the template that is mostly used in the field by the client.
Many variations of kit templates can be created for the DNA blood sampling kit based on
the collection tubes as defined for specific downstream applications. If the appropriate kit
template is not available, then the laboratory manager can create the desired kit with the
appropriate collection tubes. The kit template consists of a list of components required by
the client for sample collection and subsequent shipment. Supplementary Fig. B.1 shows a
DNA blood sampling kit template with two components: one pair of gloves and two blood
tubes.
The kit template is used to avoid the recurring selection of components during kit as-
sembly. The kit template that consists of components is imported once for every number of
kits to be assembled. In the kit assembly form (Supplementary Fig. B.2), the selected kit
template will define the components and their quantities that must be added to each kit. The
biobank staff member will select the specific kit template from a drop-down menu and the
total number of kits that must be prepared (based on the client’s requirements).
The kit assembly form specifies which stored stock items are to be used for the assembly
of the kit from a list of stock items that underlies the inventory management system. The
number of consumables that are required for the kit assembly is tracked and audited within
the inventory management system. Biobank staff can follow this audit trail to know when
consumables are running low and need to be restocked. The biobank staff members store the
assembled kits in the corresponding storage under the correct conditions until the kits are
shipped to the client.
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Kit price estimated based on product
prices, quantities and VAT 
List of products and their quantities 
in kits assembled using this template 
Fig. B.1 Creation of a DNA blood sampling kit. Product list field shows the list
of products and their equivalent quantities to use in the kit assembly process.
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This viewlet allows creation of  a batch of kits
Fig. B.2 Kits creation. The specific kit template (DNA blood sampling kit) is
selected and other details are added. This information is then ready for someone
to physically collect materials from the storage room. Consumables are scanned
to tell inventory system that a number of consumables have been released for kit
assembly.
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Shipping
The Biobank in consultation with the client defines the appropriate containers to ship to
the client. The kits are assembled as per Kit assembly section. In our example below, one
kit was prepared that contains one predesigned barcoded acid citrate dextrose collection
tube with an assigned function associated with the label in a size-appropriate styrofoam box
(Supplementary Fig. B.3(a)). The collection tubes are secured with laboratory tape with
the barcoded label facing down. Absorbent material is placed within the cavity of the box
and covers all components. A lid is added and waterproof tape used to seal the lid to the
body of the box. The sealed styrofoam box is placed in a presslock plastic bag. The plastic
sealed kit is placed within a corrugated shipping carton box (Supplementary Fig. B.3(b-d))
with an associated manifest (Supplementray Fig. B.4) in the pockets of the plastic bags. The
courier waybill, commercial invoices, and permits if applicable are placed on the outside
of courier box not covering the markings on the box. The shipping notification/manifest
(Supplementary Fig. B.4) and the confirmation and query forms are sent to the biobank to
notify them of an incoming shipment.
Other required regulatory documentation that accompanies all shipments may be loaded
to the LIMS before shipments or is emailed to the receiving laboratory or biobank. These
include the ethic approval documentation; the biospecimens deposit material transfer agree-
ment and permits. Submission sites also have to notify the receiving laboratory and biobank
of incoming shipments and prepare the following required forms before shipment. A ship-
ment checklist is completed by the submission site and is for internal use only. The shipment
manifest/notification and the shipment receipt confirmation and query form should be sent
by email to the receiving site at the time of shipment. The courier’s waybill number and
copies of commercial invoice and permits must also be sent with the shipment.
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(a) (b)
(c) (d)
Fig. B.3A kit comprising collection tube and the associated components prepared
for one patient or individual.
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Fig. B.4 A shipping manifest. This form is included in the assembled kits. The
client completes this form before shipping the biospecimens to the biobank.
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Shipping instructions from the biobank
The “shipments” HTML page (Supplementary Fig. B.5) shows the list of shipment instruc-
tions including those that are pending (see tab in top lend hand corner). The “add” button
(Supplementary Fig. B.5) pops up a new window (Supplementary Fig. B.6) with a form
that captures all the instructions to ship an assembled kit to the client. The fields in this
form include the details of the courier company, a Kit-ID (defined for the assembled kit)
(Supplementary Fig. B.7), the date of shipping to the client, the person giving the shipping
instructions, and to whom the kits will be shipped. After the request, the biobank calls the
courier company to make arrangements for them to come and fetch the assembled kits.
Fig. B.5 Summary of shipments. The “add” button provides a new form (Supple-
mentary Fig. B.6) to activate the shipping instructions for an assembled kit.
Storage Management
Supplementary Fig. B.8 shows the form for storage creation. The form contains three tabs;
storage units, managed storage, and unmanaged storage.
Storage units
These sections are used for creating the structure that matches the physical storage. The
storage unit tab can contain multiple storage units as well as managed or unmanaged storage,
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Fig. B.6 Shipping information. The assembled kits are specified in this shipping
form together with the details of the courier. This form must be completed before
calling the courier company.
http://etd.uwc.ac.za/
103
Fig. B.7 Summary window for a shipping instruction. The summary shown in
this figure reflects the shipping instructions as defined in Supplementary Fig. B.3.
This information is for record keeping and represents the information needed for
the couriers to collect the biospecimens.
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but biospecimens or stock items cannot be stored directly in storage units. Storage units are
defined as “room”, “freezer”, and “shelf” (Supplementary Fig. B.8).
Fig. B.8 Form for creating storage units. Storage units are used for creating the
structure that matches the physical storage.
Managed storage
This section contains a set number of positions for storing biospecimens, for example, boxes
that can store 36 tubes each. Once all positions are occupied, the storage itself will be flagged
as occupied, and when a position becomes available, the storage becomes available too.
Items can be stored in specific positions, or the storage itself can be selected, in which case
a position is chosen automatically—useful for storage of bulk items (Supplementary Fig.
B.9).
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Fig. B.9Managed storage. Box creation with fixed number of positions.
Unmanaged storage
This section does not restrict the number of items that can be stored. These storage units
will be available for selection until they are manually flagged as occupied (Supplementary
Fig. B.10).
Inventory storage
Stock items (products) can be stored in unmanaged storage. Unmanaged storage can be
viewed as a one big location for storing stock items. There is no quanitity limit for unmanaged
storage until the end user sets the location as full.
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Fig. B.10 Unmanaged storage. No need for specifying the number of positions.
The storage can only be manually set to “fully occupied”.
Stock orders from suppliers
Stock and products should be provided before a kit is created and assembled. Specific prod-
ucts are ordered from a supplier. Supplementary Fig. B.11 shows the list of products that
are available for a supplier called “Instruments Inc”. An order is placed for 30 quantities of
“blood tubes” and 5 quantities of “gloves” and depicted in Fig. B.12.
Fig. B.11 List of products available for the supplier, Instruments Inc.
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Fig. B.12 An order submitted to supplier (Instruments Inc).
Create stock items for storages
The products are automatically created as stock items after they are received from the sup-
pliers. At this point, the stock items are ready for storage in the location defined in the next
form (Fig. B.13).
Supplementary Fig. B.13 shows the precedent order when products are received. In that
state, the user will be able to select the quantity and the storage location. There are scenarios
where the quantities received are more than the available positions in the location selected.
The system will only store the number of stock items equivalent to the number of available
positions. Note that the user can select other locations if they exist. The order will be on
state Stored only when all stock items are stored.
Fig. B.14 shows the content of the stock after storing the ordered product quantities.
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Fig. B.13 The storage levels in which stock items are stored.
Fig. B.14 Unamanaged storage after ordering. The ordered quantities stored in
Room-3.Shelf-1
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Freezer Management
In contrast to inventory management, freezer management follows a certain structure and
order for creation. This order can be obtained only with using managed storage (Supple-
mentary Fig. B.9).
Storage position engine
Three classes (content types) were used to design the freezer management module (Supple-
mentary Fig. B.15) namely; Storage Unit (room), Storage Level (freezer, shelf, and box),
and Storage Location (positions inside box).
Fig. B.15 Freezer management entity relational diagram. The loop at the storage
level allows the creation of infinite storage units.
Use case; Freezer configuration. Plone and Zope frameworks use ZODB, an object
database for storing records (objects). Objects, by following class inheritance concept, could
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be represented as a tree whereby a given object should have a parent. Supplementary Fig.
B.16 shows an example for how storage is represented in a form of a hierarchical tree.
Fig. B.16 Freezer storage tree representation. The biospecimen storage is imple-
mented in a hierarchical structure. The root of the hierarchy and the intermediate
levels are storage units and the leaves are storage positions.
For both biospecimen storage and inventory management, positions are set up once for
every freezer, cupboard or room, during system configuration and only again when new
freezers arrive or older ones are decommissioned.
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Biospecimen Storage Management
Following the structure described in the precedent section, biospecimens and aliquots can
be stored in position within boxes created using “Managed storage” form (Supplementary
Fig. B.9).
Graphical representation
The different storage positions for biospecimens are graphically depicted in Supplementary
Fig. B.17. Each circle represents an object position. A state of a position could be “free”,
“reserved”, or “occupied”. Different colors are associated to the different states; green for a
free state, blue for reserved state, and red for occupied state.
Fig. B.17 Graphical representation of a box of 36 positions. The first position is
occupied and the two next are reserved for later usage.
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Sample storage workflow
The following workflowwas implemented to keep track of the storage position’s status; First,
the position created will have “Free” state. When creating a biospecimen, the selected stor-
age position will change state to “Reserved”. When the biospecimen is physically stored, the
storage position state will change automatically to “Occupied” (Supplementary Fig. B.18).
Fig. B.18 Storage location workflow. The status of a storage position is either
free, reserved, or occupied. The transitions between the states can be triggered by
authorised users.
Biospecimen Registration
The client returns back the kits received from the biobank after collection. A biospecimen
is a material taken from human body, such as tissue, blood, plasma, stool, and urine that can
be used for diagnosis and analysis. A biobank staff member opens the kits and registers the
biospecimen information into the system. Baobab LIMS allows creation of unique biospec-
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imen or batch of biospecimens. Supplementary Fig. B.19 is a form for creating batch of
biospecimens.
Fig. B.19 Sample batch form creation. Title, Project and the number of biospec-
imens are required fields.
http://etd.uwc.ac.za/
114 Supplementary data
Analysis request (AR)
The client requests for an analysis to be carried out on a specific biospecimens based on the
case study of a particular project. The form used for creating AR is shown in Supplementary
Fig. B.20. A biobank staff member selects the biospecimen and the analysis services for use
in downstream analyses. An analyst performs the predefined experiments using laboratory
instruments and the results of the analyses are therefore captured in the LIMS (Supplemen-
tary Fig. B.21).
Fig. B.20 AR form, indicating the essential fields that must be completed by the
clients requesting for analyses to be carried out on a human specimen.
An instrument import interface for BioRad TC20
We implemented and integrated into Baobab LIMS a parser script for importing result files
generated from BioRad TC20 instrument. The import interface allows for importing results
of automated cell counting analyses that are of utility in a biomedical laboratory. A tem-
plate was created for BioRad TC20 instrument interface for the analyses import form. This
manages the submission of result files generated by instruments into the LIMS, which au-
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tomatically imports the data after upload to avoid any form of transcription errors. BioRad
TC20 instrument result files are in comma-separated value (CSV) format. The user can up-
load the generated files into the LIMS. By clicking on the submission button, the data in the
file will be parsed and inserted in the LIMS database. The import process will significantly
decrease the turnaround time and enhance accuracy of results (Supplementary Fig. B.21).
Fig. B.21 Selection of life technology instrument import interface and specifying
the necessary analyses done using the instrument, and uploading the required file
to be imported into the LIMS. The results are successfully imported into the LIMS
database.
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